psoriasis: An autoimmune condition characterized by red, well-delineated plaques with silvery scales that are usually on the extensor surfaces and scalp. They can occasionally present with these manifestations: pustules; erythema and scaling in intertriginous areas, and erythroderma, that are often distributed on extensor surfaces and scalp.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
12722 |
4. Check minimum number of eventsNone |
12722 |
5. Include endpoints |
13225 |
6. Filter based on genotype QC (FinnGen only) |
13225 |
Control definitions (FinnGen only)
- Control exclude
- L12_PAPULOSQUAMOUS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L40-L45
- Name in latin
- Psoriasis
Similar endpoints
↥List of similar endpoints to
Psoriasis
based on the number of shared cases.
Similar with more cases:
- Papulosquamous disorders
- Autoimmune diseases related-to ILD
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Diseases of the skin and subcutaneous tissue
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 86247 | 41718 | 43977 |
| Only index persons | 78371 | 38990 | 39381 |
| Unadjusted period prevalence (%) | |||
| Whole population | 1.21 | 1.19 | 1.23 |
| Only index persons | 1.47 | 1.43 | 1.50 |
| Median age at first event (years) | |||
| Whole population | 50.13 | 51.32 | 48.96 |
| Only index persons | 49.42 | 50.73 | 48.14 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 13225 | 7007 | 6218 |
| Unadjusted period prevalence (%) | 2.55 | 2.39 | 2.74 |
| Median age at first event (years) | 51.41 | 50.62 | 52.29 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 11965
- Matched controls
- 119649
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
1334.9
323.0
3572
38
L40.4
ICD-10 Finland
Guttate psoriasis
344.6
323.0
532
16
6961A
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]
+∞
323.0
383
*
A07EC01
ATC
sulfasalazine; oral, rectal
7.1
323.0
2499
4285
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
8.5
323.0
3787
6209
TQW80
NOMESCO Finland
Local dermatologic skincare
10.7
323.0
929
931
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
12.3
323.0
1126
998
D07AC01
ATC
betamethasone; topical
7.6
323.0
8031
25377
D07AC13
ATC
mometasone; topical
4.8
323.0
6123
21266
D05AA
ATC
Tars
42.4
323.0
476
117
D07AB08
ATC
desonide; topical
4.1
323.0
2154
6070
E000001
ATC
NA
5.4
323.0
4901
13586
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.9
323.0
3803
16473
S91
ICPC
Psoriasis
94.6
323.0
844
96
L40.5
ICD-10 Finland
Arthropathic psoriasis
946.4
323.0
2661
36
D07AD01
ATC
clobetasol; topical
10.1
323.0
5369
8929
L40.8
ICD-10 Finland
Other psoriasis
198.3
323.0
933
51
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.5
323.0
1958
5035
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.6
323.0
1990
3524
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
7.6
323.0
2152
3366
69619
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)
+∞
323.0
530
*
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
30.9
323.0
800
277
H02AB06
ATC
prednisolone; systemic
2.3
323.0
6272
38983
E0000UV
ATC
NA
6.3
323.0
8108
30021
E000002
ATC
NA
4.4
323.0
2461
6634
D05AX02
ATC
calcipotriol; topical
73.3
323.0
4205
876
L40.0
ICD-10 Finland
Psoriasis vulgaris
711.6
323.0
7424
271
L40
ICD-10 Finland
Psoriasis
63.4
323.0
1658
303
L04AC10
ATC
secukinumab; parenteral
110.2
323.0
384
36
319
Kela drug reimbursment
Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)
3577.5
323.0
696
*
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
+∞
323.0
342
*
D05BB02
ATC
acitretin; oral
82.4
323.0
2356
355
M07.3
ICD-10 Finland
Other psoriatic arthropathies
391.4
323.0
1550
46
D05AX52
ATC
calcipotriol, combinations; topical
75.3
323.0
5969
1557
D07AB02
ATC
hydrocortisone butyrate; topical
3.6
323.0
5124
20522
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
16.4
323.0
4713
4572
M07.0*L40.5
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
974.3
323.0
378
*
E000003
ATC
NA
8.8
323.0
1550
1995
L04AB04
ATC
adalimumab; parenteral
15.1
323.0
917
656
L40.9
ICD-10 Finland
Psoriasis, unspecified
128.4
323.0
1641
148
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.0
323.0
2848
11424
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
84.6
323.0
1448
194
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
11.8
323.0
1156
1077
D05AX03
ATC
calcitriol; topical
101.9
323.0
1513
170
D02AE01
ATC
carbamide; topical
5.6
323.0
1689
3437
D07XC01
ATC
betamethasone, combinations; topical
19.5
323.0
6244
6335
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
11.3
323.0
1603
1612
L04AA13
ATC
leflunomide; oral
10.6
323.0
936
954
134
Kela drug reimbursment
General erythroderma
107.0
313.0
343
33
L04AB01
ATC
etanercept; parenteral
12.3
312.3
585
496
L88
ICPC
Rheumatoid/seropositive arthritis
5.9
309.8
924
1666
E000006
ATC
NA
3.9
296.4
1330
3677
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.4
291.1
1569
5043
L04AA32
ATC
apremilast; oral
+∞
290.8
278
*
6960A
ICD-9 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
281.3
269
*
D07BC01
ATC
betamethasone and antiseptics; topical
2.8
270.6
1962
7725
L04AC05
ATC
ustekinumab; parenteral
51.3
255.4
310
62
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
247.6
5329
34956
M13.9
ICD-10 Finland
Arthritis, unspecified
3.5
246.9
1272
3918
E000007
ATC
NA
4.0
240.0
1044
2785
L04AC13
ATC
ixekizumab; parenteral
477.1
236.0
235
5
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
50.7
224.5
273
55
D02AX
ATC
Other emollients and protectives
5.4
216.5
696
1360
L04AD01
ATC
ciclosporin; systemic
7.1
206.0
528
769
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.5
205.1
1821
7956
M07.0
ICD-10 Finland
Distal interphalangeal psoriatic arthropathy
339.4
200.2
202
6
D07AA02
ATC
hydrocortisone; topical
2.4
196.0
1889
8602
M07.2*L40.5
ICD-10 Finland
Psoriatic spondylitis
+∞
194.3
186
*
M25.5
ICD-10 Finland
Pain in joint
1.9
190.5
3558
21564
D05AX05
ATC
tazarotene; topical
155.6
188.1
199
13
L04AC16
ATC
guselkumab; systemic
1793.2
174.3
169
*
J01DB01
ATC
cefalexin; oral
1.9
168.2
9672
82706
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
167.7
1170
4406
XQ848
NOMESCO Finland
Dermatological photography
5.5
166.8
522
984
L04AA01
ATC
[U] ciclosporin; systemic
7.5
161.6
398
545
D07CC01
ATC
betamethasone and antibiotics; topical
2.3
158.8
1744
8393
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.7
156.4
1211
4847
L04AB06
ATC
golimumab; parenteral
12.1
145.3
273
231
69600
ICD-8 Finland
Psoriasis and similar disorders, Psoriatic arthropathy
+∞
144.0
138
*
P01BA02
ATC
hydroxychloroquine; oral
2.6
140.5
1138
4661
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
5.4
139.2
439
834
D09AB01
ATC
zinc bandage without supplements; topical
5.8
139.0
413
730
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
4.9
129.0
449
952
D07XB01
ATC
flumetasone, combinations; topical
11.8
128.4
243
209
A46
ICD-10 Finland
Erysipelas
2.1
127.0
1685
8745
XQ802
NOMESCO Finland
Epicutan test
3.6
126.6
624
1825
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.1
126.5
421
850
J01FF01
ATC
clindamycin; systemic
1.7
118.7
3159
20832
E000004
ATC
NA
4.8
116.0
408
874
L40.1
ICD-10 Finland
Generalized pustular psoriasis
+∞
115.8
111
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.9
115.7
748
2659
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
113.7
3410
23199
299
Kela drug reimbursment
NA
+∞
112.7
108
*
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
112.6
1172
5435
L30.3
ICD-10 Finland
Infective dermatitis
3.6
112.6
546
1574
H02AB07
ATC
prednisone; oral
1.9
105.9
1667
9199
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
5.9
104.2
303
521
N02AX02
ATC
tramadol; systemic, rectal
1.5
102.8
4696
35310
D07AC14
ATC
methylprednisolone aceponate; topical
2.9
102.7
669
2387
L43.8
ICD-10 Finland
Other lichen planus
18.6
102.2
160
87
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
102.0
4547
33975
A02BC02
ATC
pantoprazole; systemic
1.5
102.0
7174
59423
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.2
101.6
1191
5821
D05AC01
ATC
dithranol; topical
87.0
100.2
112
13
M01AH05
ATC
etoricoxib; oral
1.5
96.0
6655
54574
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
5.8
94.1
279
492
J01DA01
ATC
[U] cefalexin; systemic
1.5
93.8
7037
58547
TNG10
NOMESCO Finland
Puncture of knee
6.4
92.8
254
404
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
4.1
91.0
373
929
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.9
90.4
394
1037
N02BE01
ATC
paracetamol; systemic, rectal
1.6
89.5
9717
87292
L04AB05
ATC
certolizumab pegol; parenteral
14.3
88.5
153
108
A10BA02
ATC
metformin; oral
1.6
83.0
2844
19713
M45
ICD-10 Finland
Ankylosing spondylitis
3.9
82.1
352
913
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
79.7
2997
21211
D05AX
ATC
Other antipsoriatics for topical use
107.0
77.9
85
8
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
76.4
2318
15527
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
4.0
75.4
319
818
L04AA11
ATC
[U] etanercept; parenteral
11.4
74.6
143
127
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
74.6
5844
47992
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
74.1
3053
21993
L04AC18
ATC
risankizumab; parenteral
+∞
74.0
71
*
M01CB03
ATC
auranofin; oral
8.0
73.9
173
220
M01AH01
ATC
celecoxib; oral (coxibs)
1.7
73.9
1944
12518
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
5.9
73.7
215
372
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
73.0
2711
19054
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.2
71.8
397
1263
WZA10
NOMESCO Finland
Long statement of health and health related matters
4.7
71.1
250
536
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.8
70.9
1430
8502
L43.0
ICD-10 Finland
Hypertrophic lichen planus
87.3
70.0
78
9
L20
ICPC
Joint symptom/complaint NOS
2.9
69.1
443
1558
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.5
67.6
2505
17551
L04AX01
ATC
azathioprine; systemic
2.5
67.0
557
2288
XQ800
NOMESCO Finland
Prick test
2.1
67.0
831
4133
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
65.4
1002
5412
L40.2
ICD-10 Finland
Acrodermatitis continua
641.7
64.9
64
*
R06AE07
ATC
cetirizine; oral
1.4
64.8
4581
36559
D07AB01
ATC
clobetasone; topical
2.9
64.8
408
1419
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
5.6
64.5
196
357
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
64.3
2687
19306
M01CB01
ATC
sodium aurothiomalate; parenteral
4.5
63.5
234
527
M01AC06
ATC
meloxicam; systemic, rectal
1.4
63.3
3875
30074
291
Kela drug reimbursment
Tofacitinib
15.3
62.8
105
69
M01AE02
ATC
naproxen; oral, rectal
1.4
61.9
6066
51106
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
61.5
4908
39901
N05BB01
ATC
hydroxyzine; systemic
2.1
60.6
703
3394
M54.5
ICD-10 Finland
Low back pain
1.4
60.5
3391
25821
S29
ICPC
Skin symptom/complaint other
1.6
60.1
1681
10947
T90
ICPC
Diabetes non-insulin dependent
1.5
60.0
2276
15966
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.6
57.8
447
1763
SPAT1263
SPAT
Sampling
1.4
57.5
4342
34834
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.9
57.1
361
1260
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
56.8
1180
7052
NG1DA
NOMESCO Finland
X-ray of knees
3.6
55.9
261
729
M09.0*L40.5
ICD-10 Finland
Juvenile arthritis in psoriasis
+∞
55.2
53
*
M04AA01
ATC
allopurinol; systemic
1.7
55.1
1223
7449
R03AC02
ATC
salbutamol; inhalant
1.4
55.1
5481
45922
C03CA01
ATC
furosemide; systemic
1.5
54.2
2473
18002
H02AB04
ATC
methylprednisolone; systemic
1.6
53.8
1499
9725
UJF32
NOMESCO Finland
Coloscopy
1.5
53.4
2547
18698
D07AC03
ATC
desoximetasone; topical
3.6
52.9
248
696
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
52.1
2153
15329
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
52.1
747
3925
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
5.5
52.0
158
289
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
52.0
1309
8259
SPAT1262
SPAT
Handing over of treatment supplies
1.5
51.6
1808
12402
L30.0
ICD-10 Finland
Nummular dermatitis
2.6
51.5
396
1555
WQ031
NOMESCO Finland
NA
510.1
51.5
51
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
51.4
1740
11840
L04AA29
ATC
tofacitinib; oral
11.2
50.7
97
87
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
50.1
833
4616
S18
ICPC
Laceration/cut
1.4
49.7
4235
34412
ZX140
NOMESCO Finland
Intra articular
5.7
49.6
146
257
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
6.1
49.5
138
227
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
49.4
1098
6677
L20.0
ICD-10 Finland
Besnier prurigo
2.0
49.3
655
3339
G47.3
ICD-10 Finland
Sleep apnoea
1.5
48.8
2255
16400
J01AA02
ATC
doxycycline; systemic
1.4
48.8
8494
76924
L04AA17
ATC
[U] adalimumab; parenteral
9.8
48.6
100
103
Z71.8
ICD-10 Finland
Other specified counselling
1.5
48.6
2333
17102
L17
ICPC
Foot/toe symptom/complaint
1.4
48.4
2429
17959
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.6
48.3
1492
9918
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
48.2
3833
30751
L43.9
ICD-10 Finland
Lichen planus, unspecified
5.8
48.0
140
244
S21
ICPC
Skin texture symptom/complaint
1.7
47.9
1203
7575
WX110
NOMESCO Finland
Local anesthesy
1.3
47.4
7378
65490
3005
Kela drug reimbursment
Tofacitinib
11.0
47.2
91
83
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
47.1
914
5332
R4120
NOMESCO Finland
Occupational therapy
2.0
46.8
661
3453
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.0
46.8
677
3568
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
46.8
5838
50118
R4180
NOMESCO Finland
Podiatric therapy
4.7
46.6
165
358
C08CA01
ATC
amlodipine; oral
1.4
46.3
3357
26487
M01AH02
ATC
rofecoxib; oral
1.6
46.2
1292
8366
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
46.1
983
5900
M07.1*L40.5
ICD-10 Finland
Arthritis mutilans
+∞
45.8
44
*
M01AB05
ATC
diclofenac; systemic, rectal
1.3
45.8
7198
63803
E66.00
ICD-10 Finland
Metabolic syndrome
2.0
45.7
589
2966
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
8.4
45.6
102
122
M07.2
ICD-10 Finland
Psoriatic spondylitis
449.5
45.3
45
*
M073L
ICD-10 Finland
NA
+∞
44.8
43
*
D01AC02
ATC
miconazole; topical
1.8
44.5
814
4655
N03AX16
ATC
pregabalin; oral
1.4
43.9
2329
17356
RJ411
NOMESCO Finland
NA
6.6
43.4
114
174
R4110
NOMESCO Finland
Physiotherapy
1.4
43.4
2623
20014
P01AB01
ATC
metronidazole; oral, rectal
1.3
42.9
3967
32438
J02AC01
ATC
fluconazole; systemic
1.3
42.8
3894
31755
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
42.8
3938
32170
6961D
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PUSTULOSIS PALMOPLANTARIS]
+∞
42.7
41
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
42.7
7516
67338
M79.6
ICD-10 Finland
Pain in limb
1.3
42.7
3495
28038
L28
ICPC
Limited function/disability (L)
1.6
42.6
1358
9074
EBA00
NOMESCO Finland
Extraction of tooth
1.4
42.5
3296
26210
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
42.3
1252
8216
J01AA07
ATC
tetracycline; systemic
1.5
42.0
1502
10312
D01AE15
ATC
terbinafine; topical
1.8
41.8
714
3989
S97
ICPC
Chronic ulcer skin
2.0
41.7
528
2640
68693
ICD-8 Finland
Other local infections of skin and subcutaneous tissue, Pustulosis palmo-plantaris
+∞
41.7
40
*
XX9XE
NOMESCO Finland
Other ultrasound examination
4.7
41.2
144
309
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
40.6
1047
6622
C07AB07
ATC
bisoprolol; oral
1.3
40.3
4464
37373
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.1
40.3
506
2518
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
40.3
1994
14636
S76
ICPC
Skin infection other
2.0
40.0
513
2578
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
40.0
1268
8457
K02.1
ICD-10 Finland
Caries of dentine
1.3
39.9
5924
51605
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
39.5
4259
35489
WZA90
NOMESCO Finland
Other doctors statement
1.4
39.1
2259
17052
A02BC01
ATC
omeprazole; systemic
1.4
39.1
2629
20370
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.7
39.0
851
5135
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
3.8
39.0
169
446
R06.0
ICD-10 Finland
Dyspnoea
1.4
38.7
2286
17317
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
38.7
2971
23517
L30.8
ICD-10 Finland
Other specified dermatitis
2.8
38.5
256
925
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.0
38.5
495
2491
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.6
38.3
955
5985
J01FA06
ATC
roxithromycin; oral
1.3
38.3
4066
33767
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
38.1
3446
27957
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
38.0
849
5159
L26
ICD-10 Finland
Exfoliative dermatitis
11.7
37.6
70
60
E66.8
ICD-10 Finland
Other obesity
2.0
37.5
534
2797
N07BA03
ATC
varenicline; oral
1.9
36.9
550
2927
D01BA02
ATC
terbinafine; oral; topical
1.4
36.8
2490
19277
UJF30
NOMESCO Finland
Ileoscopy through colon
1.6
36.8
913
5711
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
36.6
1660
11951
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
36.6
1039
6732
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
36.6
772
4609
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.0
36.5
488
2490
WX290
NOMESCO Finland
Other blockade of nerve
1.3
36.5
4474
37825
J01AA04
ATC
lymecycline; systemic
1.5
36.4
1255
8524
205
Kela drug reimbursment
Chronic hypertension
1.4
36.2
2453
18996
J01CA04
ATC
amoxicillin; systemic
1.3
36.1
8731
80587
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
36.0
6688
59611
R03BB04
ATC
tiotropium bromide; inhalant
1.6
35.6
899
5652
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
35.4
727
4305
J01MA02
ATC
ciprofloxacin; systemic
1.3
35.3
3794
31464
D11AH04
ATC
alitretinoin; oral
23.9
35.2
50
21
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
35.1
3779
31335
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
35.1
451
2267
QXA70
NOMESCO Finland
Guidance related to rash and skin care
43.1
34.9
43
10
N06AX21
ATC
duloxetine; oral
1.6
34.9
1028
6723
A10BH01
ATC
sitagliptin; oral
1.6
34.5
869
5457
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
34.3
5435
47357
A07EC02
ATC
mesalazine; oral, rectal
1.9
34.1
561
3092
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
4.8
34.0
116
244
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
33.9
7361
66647
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
33.7
4119
34690
J02AC02
ATC
itraconazole; systemic
1.4
33.7
1732
12756
WQ021
NOMESCO Finland
NA
14.0
33.2
57
41
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
2.9
33.0
204
705
S02CA02
ATC
flumetasone and antiinfectives; otic
1.8
32.9
546
3020
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
3.6
32.9
154
435
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.0
32.9
412
2049
N05CF01
ATC
zopiclone; oral
1.3
32.9
3010
24348
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.7
32.7
670
3963
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
32.6
361
1704
J01MA12
ATC
levofloxacin; systemic
1.4
32.6
1715
12680
D07XB02
ATC
triamcinolone, combinations; topical
3.2
32.5
180
577
N03AX12
ATC
gabapentin; oral
1.4
32.5
1458
10458
M13.0
ICD-10 Finland
Polyarthritis, unspecified
3.5
32.5
157
455
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
32.3
2703
21571
D07XB05
ATC
dexamethasone, combinations; topical
2.4
32.1
283
1199
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
32.1
3691
30787
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
32.0
1488
10744
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
31.9
2698
21557
RJ421
NOMESCO Finland
NA
6.5
31.9
84
130
M40.5
ICD-10 Finland
Lordosis, unspecified
72.3
31.8
36
5
J01CF05
ATC
flucloxacillin; systemic
2.1
31.8
384
1881
L30.4
ICD-10 Finland
Erythema intertrigo
3.5
31.4
150
431
M79.7
ICD-10 Finland
Fibromyalgia
2.2
31.4
325
1489
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
31.4
2024
15497
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.4
31.3
272
1143
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
4.5
31.3
113
253
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
31.1
4896
42425
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.7
31.1
614
3591
J01FA10
ATC
azithromycin; systemic
1.3
31.1
5953
52802
SPAT1301
SPAT
No procedures
1.3
31.1
2961
24045
K50.1
ICD-10 Finland
Crohn disease of large intestine
3.3
31.1
160
487
N06AA09
ATC
amitriptyline; systemic
1.6
31.0
919
6013
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.1
31.0
175
570
M10.9
ICD-10 Finland
Gout, unspecified
1.8
30.9
578
3324
WQ053
NOMESCO Finland
NA
70.0
30.8
35
5
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
30.8
1116
7650
-1
NOMESCO Finland
NA
1.3
30.8
3242
26689
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
30.7
3201
26311
M01AB55
ATC
diclofenac, combinations; oral
1.7
30.6
628
3715
A02BC03
ATC
lansoprazole; oral
1.3
30.6
2787
22484
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.9
30.4
484
2638
WQ066
NOMESCO Finland
NA
18.1
30.4
47
26
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
30.3
2296
18021
R02
ICPC
Shortness of breath/dyspnoea
1.5
30.3
1049
7116
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
3.4
30.3
148
433
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
30.1
994
6670
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.7
30.1
618
3658
A02BC05
ATC
esomeprazole; systemic
1.3
30.1
3966
33595
RJ420
NOMESCO Finland
NA
6.5
30.1
79
122
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
10.6
29.8
58
55
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
29.8
1127
7795
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
29.5
5153
45109
N06AX11
ATC
mirtazapine; oral
1.3
29.4
3003
24584
K05.31
ICD-10 Finland
Periodontitis pronounced
1.6
29.4
921
6102
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
29.4
4033
34306
R06AE09
ATC
levocetirizine; oral
1.4
29.3
1349
9711
R06AX27
ATC
desloratadine; oral
1.3
29.2
2538
20315
WQ054
NOMESCO Finland
NA
+∞
29.2
28
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
28.8
1487
10934
ZX120
NOMESCO Finland
Intravenous
1.6
28.8
866
5684
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
28.6
2637
21277
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
28.3
2550
20498
K50.8
ICD-10 Finland
Other Crohn disease
2.9
28.3
180
634
L04AC
ATC
Interleukin inhibitors
+∞
28.1
27
*
WQ032
NOMESCO Finland
NA
+∞
28.1
27
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.5
28.0
916
6135
Z50.1
ICD-10 Finland
Other physical therapy
1.8
27.7
509
2911
SPAT1254
SPAT
Administration of medicine
1.4
27.5
1235
8840
SPAT1153
SPAT
Removal of sutures
1.3
27.5
3013
24859
M03BX02
ATC
tizanidine; oral
1.2
27.4
6480
58476
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.0
27.3
343
1711
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
27.1
1999
15594
M073, L400
ICD-10 Finland
NA
+∞
27.1
26
*
L405M
ICD-10 Finland
NA
+∞
27.1
26
*
A10AE04
ATC
insulin glargine; parenteral
1.6
27.0
834
5507
N06AB04
ATC
citalopram; systemic
1.3
27.0
1994
15558
A02BA02
ATC
ranitidine; systemic
1.4
26.9
1768
13539
M01AB01
ATC
indometacin; systemic, rectal
1.6
26.8
689
4346
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.0
26.8
333
1655
WZC30
NOMESCO Finland
Teaching
1.4
26.6
1225
8811
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
26.6
1486
11073
SPAT1312
SPAT
General health counselling
1.3
26.5
2991
24752
J01FA09
ATC
clarithromycin; systemic
1.3
26.3
3051
25330
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
2.9
26.2
164
573
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
26.2
5871
52561
D11
ICPC
Diarrhoea
1.5
26.1
954
6544
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
26.1
866
5817
4AA12
NOMESCO Finland
NA
6.9
26.0
65
94
L99
ICPC
Musculoskeletal disease other
2.6
25.9
199
786
J01FA01
ATC
erythromycin; systemic
1.4
25.9
1273
9267
M13.1
ICD-10 Finland
Monoarthritis, not elsewhere classified
3.3
25.8
130
391
R50.9
ICD-10 Finland
Fever, unspecified
1.4
25.8
1241
8996
M09.0
ICD-10 Finland
Juvenile arthritis in psoriasis
72.8
25.8
29
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.7
25.7
578
3513
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.8
25.5
173
634
A03
ICPC
Fever
1.4
25.5
1407
10453
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
25.3
1209
8749
TQW99
NOMESCO Finland
Other minor procedure on skin
1.8
25.2
429
2394
M17.5
ICD-10 Finland
Other secondary gonarthrosis
3.0
25.2
146
485
L73.2
ICD-10 Finland
Hidradenitis suppurativa
3.6
25.2
116
325
B35.3
ICD-10 Finland
Tinea pedis
1.9
25.1
359
1885
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
4.1
25.1
98
238
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.8
25.1
416
2303
L41.9
ICD-10 Finland
Parapsoriasis, unspecified
+∞
25.0
24
*
L03
ICPC
Low back symptom/complaint
1.3
25.0
2155
17180
A07EA06
ATC
budesonide; oral, local oral
2.0
24.9
321
1618
C09AA02
ATC
enalapril; systemic
1.3
24.9
1705
13131
K50.0
ICD-10 Finland
Crohn disease of small intestine
2.8
24.8
167
612
A10BJ02
ATC
liraglutide; parenteral
2.3
24.7
230
1006
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
24.7
2380
19258
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.3
24.6
237
1055
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
24.5
1140
8207
SPAT1229
SPAT
Assessment of need for aid
1.6
24.5
642
4069
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
5.2
24.5
76
146
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.0
24.4
313
1575
XQ899
NOMESCO Finland
Other assessment of skin
6.3
24.4
65
103
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
24.4
1281
9432
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
7.2
24.4
59
82
A10BK03
ATC
empagliflozin; oral
1.6
24.3
637
4038
E66.9
ICD-10 Finland
Obesity, unspecified
2.0
24.2
313
1579
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.6
24.1
184
724
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
24.0
548
3342
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.0
24.0
307
1543
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.4
24.0
212
903
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
17.7
23.9
37
21
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
23.8
1463
11062
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
22.7
23.8
34
15
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.6
23.8
635
4041
N05BA04
ATC
oxazepam; oral
1.3
23.8
2224
17914
D06BB04
ATC
podophyllotoxin; topical
1.8
23.7
456
2647
4AB02
NOMESCO Finland
NA
5.6
23.7
69
123
L12
ICPC
Hand/finger symptom/complaint
1.4
23.6
1240
9124
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.6
23.6
692
4512
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
23.6
3707
31815
R05
ICPC
Cough
1.3
23.5
2008
15972
A10BJ06
ATC
semaglutide; parenteral
2.0
23.4
303
1531
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
23.4
9986
95275
WW200
NOMESCO Finland
Immunization
2.1
23.3
264
1264
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
4.3
23.2
86
199
M01AX01
ATC
nabumetone; oral
1.8
23.1
401
2254
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
23.1
1758
13745
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
23.0
976
6900
D01AC03
ATC
econazole; topical
1.6
22.9
560
3482
L15
ICPC
Knee symptom/complaint
1.3
22.9
1831
14413
M01AX17
ATC
nimesulide; oral
1.3
22.9
2243
18165
M02AA07
ATC
piroxicam; topical
1.2
22.9
3399
28964
M13.8
ICD-10 Finland
Other specified arthritis
3.4
22.9
112
331
L21.0
ICD-10 Finland
Seborrhoea capitis
3.3
22.8
118
364
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
22.8
2423
19837
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
2.1
22.7
254
1211
B01AB05
ATC
enoxaparin; parenteral
1.3
22.6
2765
23025
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
22.5
711
4716
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
22.4
1722
13474
D07AC09
ATC
budesonide; topical
7.9
22.3
51
65
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
6.4
22.3
59
93
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.8
22.3
371
2053
J01CE08
ATC
benzathine benzylpenicillin; parenteral
3.2
22.1
120
383
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
6.2
22.0
59
95
M07
ICD-10 Finland
Psoriatic and enteropathic arthropathies
+∞
21.9
21
*
M074, L405
ICD-10 Finland
NA
+∞
21.9
21
*
WZA00
NOMESCO Finland
Short statement of of health and health related matters
1.6
21.9
541
3376
RS221
NOMESCO Finland
NA
2.6
21.8
160
618
L71.8
ICD-10 Finland
Other rosacea
2.8
21.8
143
517
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.6
21.8
615
3973
ZXA00
NOMESCO Finland
Right side
1.3
21.8
2410
19811
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
5.5
21.6
64
117
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.8
21.4
350
1927
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.4
21.4
1046
7596
SPAT1283
SPAT
Restricted health certificate
1.3
21.3
1513
11693
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
21.3
1396
10658
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.6
21.2
518
3219
C10AA01
ATC
simvastatin; oral
1.2
21.2
3806
33032
M10.0
ICD-10 Finland
Idiopathic gout
2.0
21.2
271
1366
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
21.2
784
5389
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
21.1
1790
14193
A10BB12
ATC
glimepiride; oral
1.6
21.1
554
3509
R60.0
ICD-10 Finland
Localized oedema
1.4
21.1
900
6368
R74
ICPC
Upper respiratory infection acute
1.3
21.1
2530
20993
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
3.3
21.1
107
326
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.5
21.0
711
4792
M05BA04
ATC
alendronic acid; oral
1.6
20.9
605
3928
ZXA05
NOMESCO Finland
Left side
1.3
20.9
2256
18476
T82
ICPC
Obesity
1.9
20.9
332
1813
D05AD01
ATC
trioxysalen; topical
60.1
20.8
24
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
20.8
2168
17668
N05CD07
ATC
temazepam; oral
1.4
20.8
1035
7540
L44.0
ICD-10 Finland
Pityriasis rubra pilaris
210.3
20.6
21
*
M48.0
ICD-10 Finland
Spinal stenosis
1.4
20.5
968
6979
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.7
20.5
434
2594
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
20.5
1183
8841
N05BA01
ATC
diazepam; systemic, rectal
1.4
20.4
1167
8707
SPAT1202
SPAT
Intra-articular injection
2.0
20.4
277
1428
N06AX16
ATC
venlafaxine; oral
1.4
20.4
1239
9342
H02AB08
ATC
triamcinolone; systemic
4.7
20.4
69
147
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.7
20.3
417
2470
L60.0
ICD-10 Finland
Ingrowing nail
1.8
20.3
368
2098
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.8
20.2
365
2079
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.8
20.1
340
1895
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.6
20.0
574
3721
SPAT1260
SPAT
Consultation of another employee
1.3
20.0
1558
12201
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
19.9
1444
11188
160
Kela drug reimbursment
exenatide
2.3
19.9
193
863
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.8
19.9
344
1933
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
3.0
19.8
115
386
K08.3
ICD-10 Finland
Retained dental root
1.5
19.7
601
3955
L28.0
ICD-10 Finland
Lichen simplex chronicus
3.1
19.7
111
365
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
19.7
1673
13263
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
2.3
19.6
177
765
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
19.5
661
4457
D06BX01
ATC
metronidazole; topical
1.4
19.4
896
6434
KMAK
NOMESCO Finland
NA
1.2
19.4
5186
46678
D07CB01
ATC
triamcinolone and antibiotics; topical
2.2
19.3
200
922
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.5
19.3
632
4227
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.7
19.2
399
2374
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.0
19.2
253
1293
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.7
19.1
404
2415
J20
ICD-10 Finland
Acute bronchitis
1.4
19.1
813
5746
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.5
19.0
736
5109
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
18.9
3821
33464
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
18.9
1761
14131
S06
ICPC
Rash localized
1.6
18.8
457
2840
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
18.6
2081
17082
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.0
18.6
233
1167
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.7
18.6
386
2294
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.4
18.6
1089
8158
N07.3
ICD-10 Finland
Hereditary nephropathy, not elsewhere classified, diffuse mesangial proliferative glomerulonephritis
100.2
18.5
20
*
E0001A1
ATC
NA
2.2
18.5
181
814
SPAT1310
SPAT
Counselling related to known health issue
1.2
18.4
2910
24838
EBA30
NOMESCO Finland
Excision of root of tooth
1.6
18.4
456
2850
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.8
18.3
334
1910
H60.8
ICD-10 Finland
Other otitis externa
2.0
18.3
242
1238
R95
ICPC
Chron obstructive pulmonary disease
2.1
18.3
221
1088
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
18.2
4251
37710
L43.3
ICD-10 Finland
Subacute (active) lichen planus
25.0
18.2
25
10
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.8
18.1
291
1596
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
1.9
18.1
271
1451
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
18.0
1168
8888
J01MA14
ATC
moxifloxacin; systemic
1.4
18.0
763
5388
ZX112
NOMESCO Finland
Subcutaneous
2.1
17.9
195
919
L28.1
ICD-10 Finland
Prurigo nodularis
3.7
17.9
79
217
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.9
17.8
253
1329
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.8
17.8
324
1853
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
17.8
559
3708
H01
ICPC
Ear pain/earache
1.4
17.7
860
6233
L405, L400
ICD-10 Finland
NA
+∞
17.7
17
*
NDL52
NOMESCO Finland
Tenosynovectomy of hand
3.6
17.7
79
219
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
17.7
2126
17596
S99
ICPC
Skin disease other
2.3
17.7
170
759
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
17.7
2036
16767
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
17.6
984
7309
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.0
17.5
229
1167
R53
ICD-10 Finland
Malaise and fatigue
1.3
17.5
1675
13475
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.5
17.5
606
4109
M35.7
ICD-10 Finland
Hypermobility syndrome
2.6
17.4
125
479
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.2
17.4
171
773
Z72.0
ICD-10 Finland
Tobacco use
2.0
17.2
220
1110
A01
ICPC
Pain general/multiple sites
1.5
17.2
606
4120
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
17.1
1784
14504
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
17.1
1366
10717
A06AD11
ATC
lactulose; oral
1.3
17.1
1091
8278
L71.9
ICD-10 Finland
Rosacea, unspecified
2.1
17.1
196
945
RD210
NOMESCO Finland
NA
2.2
17.0
166
747
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
5.5
17.0
50
92
R05FB02
ATC
cough suppressants and expectorants
1.2
17.0
3507
30703
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
2.4
16.9
137
563
A07AA02
ATC
nystatin; oral
1.6
16.9
492
3202
L85.89
ICD-10 Finland
Other specified epidermal thickening
7.0
16.8
41
59
L84
ICD-10 Finland
Corns and callosities
1.8
16.7
279
1550
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
2.5
16.7
131
527
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.6
16.7
442
2809
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
2.1
16.6
188
904
N05AH04
ATC
quetiapine; oral
1.3
16.6
1419
11240
L16
ICPC
Ankle symptom/complaint
1.4
16.6
826
6011
S10
ICPC
Boil/carbuncle
1.6
16.5
454
2913
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.8
16.5
308
1776
C09CA01
ATC
losartan; oral
1.2
16.4
2052
17043
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
2.4
16.4
133
547
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
3.5
16.4
76
218
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
16.4
1108
8486
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.7
16.3
307
1774
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
1.9
16.3
232
1219
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
4.2
16.3
61
145
WX320
NOMESCO Finland
Spinalanesthesy
1.2
16.3
1969
16290
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
3.6
16.3
73
204
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.0
16.2
208
1054
N06AB10
ATC
escitalopram; oral
1.3
16.2
1734
14142
L04AA24
ATC
abatacept; parenteral
4.6
16.2
55
119
B01AC04
ATC
clopidogrel; oral
1.3
16.2
1207
9381
K07.60
ICD-10 Finland
Snapping jaw
1.6
16.1
387
2403
K05.30
ICD-10 Finland
Periodontitis complex
1.3
16.0
1057
8063
R52.2
ICD-10 Finland
Other chronic pain
1.8
16.0
276
1552
M17.4
ICD-10 Finland
Other secondary gonarthrosis, bilateral
4.5
16.0
56
125
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.8
15.9
270
1514
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
15.9
505
3359
L08.0
ICD-10 Finland
Pyoderma
2.9
15.7
93
318
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
15.7
799
5837
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.0
15.7
195
973
N06AB03
ATC
fluoxetine; oral
1.3
15.7
1081
8297
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
15.7
889
6615
G44.2
ICD-10 Finland
Tension-type headache
1.3
15.7
1074
8238
M06
ICD-10 Finland
Other rheumatoid arthritis
3.7
15.7
67
180
R52.9
ICD-10 Finland
Pain, unspecified
1.4
15.6
695
4953
M073, L403
ICD-10 Finland
NA
+∞
15.6
15
*
RS340
NOMESCO Finland
NA
5.4
15.6
46
85
N02AA05
ATC
oxycodone; systemic
1.3
15.6
1136
8790
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.3
15.6
1024
7801
H60.3
ICD-10 Finland
Other infective otitis externa
2.0
15.6
197
993
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
1.9
15.6
214
1113
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.7
15.6
307
1799
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.5
15.5
117
463
NH3AE
NOMESCO Finland
Feet ultrasound examination
4.9
15.4
50
103
W19
ICD-10 Finland
Unspecified fall
1.4
15.4
750
5437
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
2.4
15.3
125
515
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
2.6
15.3
112
436
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.3
15.3
1640
13365
TNC11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in elbow joint
5.0
15.2
48
96
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
2.8
15.2
96
343
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.4
15.1
866
6454
C10AA05
ATC
atorvastatin; oral
1.2
15.1
3348
29432
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.4
15.0
910
6844
ZXA10
NOMESCO Finland
Bilateral
1.3
15.0
1531
12396
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
3.6
15.0
67
187
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
2.6
15.0
107
412
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.5
15.0
484
3231
RT272
NOMESCO Finland
NA
4.9
15.0
48
98
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.0
14.9
189
954
L01
ICPC
Neck symptom/complaint
1.3
14.9
1115
8664
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.2
14.9
3449
30430
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
14.8
1350
10775
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
14.8
1052
8108
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
1.7
14.8
291
1705
D07AC04
ATC
fluocinolone acetonide; topical
7.6
14.8
34
45
A41.9
ICD-10 Finland
Sepsis, unspecified
1.8
14.8
271
1553
L41.1
ICD-10 Finland
Pityriasis lichenoides chronica
56.7
14.8
17
*
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.0
14.8
181
901
M19.2
ICD-10 Finland
Other secondary arthrosis
2.4
14.7
119
490
C03DA01
ATC
spironolactone; oral
1.4
14.7
809
5990
C03AA03
ATC
hydrochlorothiazide; oral
1.4
14.7
724
5261
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.4
14.7
605
4252
C10AC01
ATC
colestyramine; oral
1.9
14.6
218
1169
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.4
14.5
857
6426
L04AA21
ATC
efalizumab; parenteral
150.2
14.5
15
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.7
14.5
317
1920
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
4.3
14.4
52
120
TNH10
NOMESCO Finland
Joint puncture, ankle joint or foot joint
6.7
14.4
36
54
R51.80
ICD-10 Finland
Headache
1.3
14.4
1205
9508
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
14.4
1241
9835
R03BA05
ATC
fluticasone; inhalant
1.3
14.3
1552
12656
R21
ICPC
Throat symptom/complaint
1.3
14.3
1609
13179
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
14.3
839
6276
K51.5
ICD-10 Finland
Left sided colitis
1.8
14.3
239
1332
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.2
14.3
2144
18133
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
14.2
2417
20701
A10AE05
ATC
insulin detemir; parenteral
1.5
14.2
451
3000
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.7
14.2
294
1754
S22
ICPC
Nail symptom/complaint
1.5
14.1
453
3017
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.8
14.1
224
1228
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
14.1
2589
22340
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.1
14.1
158
761
J05AB01
ATC
aciclovir; systemic
1.2
14.1
1778
14763
162
Kela drug reimbursment
liraglutide
2.5
14.0
110
445
T78.4
ICD-10 Finland
Allergy, unspecified
1.6
14.0
347
2173
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.6
14.0
379
2427
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.7
14.0
276
1622
TQW40
NOMESCO Finland
Remowal of suture of skin
1.4
13.9
601
4258
SPAT1255
SPAT
Intravenous administration of medicine
1.5
13.9
520
3580
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
2.8
13.8
86
305
L08
ICPC
Shoulder symptom/complaint
1.2
13.8
1607
13213
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.5
13.8
505
3465
UJF92
NOMESCO Finland
Capsular endoscopy
2.0
13.8
176
893
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
3.2
13.8
72
228
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.3
13.7
1135
8941
K04.0
ICD-10 Finland
Pulpitis
1.4
13.7
803
6011
3029
Kela drug reimbursment
Upadacitinib
13.5
13.7
23
17
A10BK01
ATC
dapagliflozin; oral
1.6
13.6
366
2340
C07AB02
ATC
metoprolol; systemic
1.2
13.6
1614
13299
WX002
NOMESCO Finland
Sedation and analgesia
1.2
13.6
1692
14017
ZXC50
NOMESCO Finland
Cryotherapy
1.8
13.6
221
1220
WQ068
NOMESCO Finland
NA
75.2
13.6
15
*
L41.3
ICD-10 Finland
Small plaque parapsoriasis
75.2
13.6
15
*
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.2
13.6
1869
15656
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.4
13.5
683
4985
L11
ICPC
Wrist symptom/complaint
1.4
13.4
597
4257
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.1
13.4
155
754
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
2.1
13.3
147
700
R05
ICD-10 Finland
Cough
1.2
13.3
1629
13464
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
1.6
13.3
342
2163
SPAT1216
SPAT
Assessment of functional ability
1.3
13.3
1146
9074
RT271
NOMESCO Finland
NA
5.9
13.2
36
61
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.3
13.2
903
6918
J31.0
ICD-10 Finland
Chronic rhinitis
1.4
13.2
638
4617
WX408
NOMESCO Finland
General anesthesy, balanced
1.2
13.2
2412
20782
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
2.0
13.2
160
794
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
1.5
13.2
422
2812
212
Kela drug reimbursment
Gout
2.1
13.1
151
735
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
13.1
2297
19709
R60.9
ICD-10 Finland
Oedema, unspecified
1.6
13.1
362
2332
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.0
13.1
171
876
SPAT1325
SPAT
Vaccination
1.2
13.1
2898
25407
AA1AD
NOMESCO Finland
CT of head and brain
1.2
13.1
1960
16558
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
13.1
1692
14074
WXQ24
NOMESCO Finland
UVB/UVA light therapy
15.0
13.1
21
14
J45.1
ICD-10 Finland
Nonallergic asthma
1.4
13.0
554
3919
RS121
NOMESCO Finland
NA
3.1
13.0
69
221
P17
ICPC
Tobacco abuse
2.2
13.0
125
562
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
12.9
2839
24867
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.4
12.9
780
5867
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.0
12.9
74
248
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.3
12.9
815
6175
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
1.8
12.9
215
1200
P06
ICPC
Sleep disturbance
1.4
12.9
777
5843
N06AA12
ATC
doxepin; systemic
1.5
12.9
414
2761
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.4
12.8
754
5646
L14
ICPC
Leg/thigh symptom/complaint
1.4
12.8
558
3963
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.8
12.8
235
1352
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.4
12.8
776
5840
K59.1
ICD-10 Finland
Functional diarrhoea
1.5
12.8
389
2563
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.5
12.8
434
2931
R42
ICD-10 Finland
Dizziness and giddiness
1.2
12.8
1739
14545
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.4
12.7
764
5742
NF1DA
NOMESCO Finland
X-ray of hips
1.9
12.7
182
964
WQ020
NOMESCO Finland
NA
9.6
12.7
25
26
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.4
12.6
631
4597
K04.1
ICD-10 Finland
Necrosis of pulp
1.3
12.6
877
6741
L29
ICPC
Musculoskeletal sympt/complt other
1.4
12.6
573
4107
R06AX22
ATC
ebastine; oral
1.2
12.6
1461
12001
SGA01
NOMESCO Finland
Tooth opening as first aid
1.3
12.6
1379
11254
W10
ICD-10 Finland
Fall on and from stairs and steps
1.5
12.6
385
2543
C84.0
ICD-10 Finland
Mycosis fungoides
7.8
12.6
28
36
NK4AT
NOMESCO Finland
Puncture of joint with ultrasound guidance not elsewher classified
2.8
12.5
80
290
288
Kela drug reimbursment
Febuxostat
4.1
12.5
47
114
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
1.7
12.5
274
1664
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
2.5
12.5
94
374
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.5
12.5
390
2589
M07.1
ICD-10 Finland
Arthritis mutilans
130.1
12.4
13
*
M25.4
ICD-10 Finland
Effusion of joint
2.3
12.4
115
508
SFA00
NOMESCO Finland
Small filling
1.3
12.4
1074
8510
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
1.8
12.4
194
1062
M70.6
ICD-10 Finland
Trochanteric bursitis
1.3
12.4
904
6997
R96
ICPC
Asthma
1.4
12.4
685
5078
RS222
NOMESCO Finland
NA
2.4
12.4
106
450
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
12.4
925
7186
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
1.7
12.3
236
1376
H01.0
ICD-10 Finland
Blepharitis
1.5
12.3
427
2898
A10BX07
ATC
[U] liraglutide; parenteral
2.3
12.3
114
504
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
3.1
12.3
65
209
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
5.3
12.2
36
68
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
12.2
2322
20066
J01DA06
ATC
[U] cefuroxime; systemic
1.3
12.2
1263
10239
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
1.9
12.2
178
952
A28
ICPC
Limited function/disability NOS
1.3
12.2
1015
8005
ACC51
NOMESCO Finland
Release of median nerve
1.4
12.1
591
4290
R03BA02
ATC
budesonide; inhalant
1.2
12.1
1465
12090
L57.0
ICD-10 Finland
Actinic keratosis
1.4
12.1
658
4862
R06.2
ICD-10 Finland
Wheezing
1.6
12.1
333
2144
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.2
12.1
1693
14197
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.3
12.0
1211
9780
P76
ICPC
Depressive disorder
1.5
12.0
467
3245
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.4
12.0
585
4244
NG2CA
NOMESCO Finland
X-ray of patella with specialised projection
3.4
12.0
56
164
WXQ26
NOMESCO Finland
UVB broad spectrum light therapy
21.3
12.0
17
8
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
2.1
11.9
127
599
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.5
11.9
419
2856
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
11.9
476
3331
-69
ICPC
Other reason for encounter NEC
1.6
11.9
299
1886
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
1.9
11.8
169
896
B03BA03
ATC
hydroxocobalamin; parenteral
1.5
11.8
404
2735
P03
ICPC
Feeling depressed
1.4
11.8
677
5052
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
3.8
11.8
48
126
Z01.7
ICD-10 Finland
Laboratory examination
1.3
11.7
882
6859
H02AB09
ATC
hydrocortisone; systemic
1.8
11.7
184
1010
S87
ICPC
Dermatitis/atopic eczema
1.9
11.7
174
938
R01AD09
ATC
mometasone; nasal
1.2
11.6
4201
38213
6929X
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]
5.0
11.6
36
72
L60.9
ICD-10 Finland
Nail disorder, unspecified
2.3
11.5
106
466
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.7
11.5
244
1467
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.7
11.5
237
1413
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.6
11.5
264
1621
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.4
11.5
470
3299
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.5
11.5
420
2885
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.5
11.5
424
2917
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
1.9
11.5
152
785
R4190
NOMESCO Finland
Nutritional therapy
1.6
11.5
262
1606
SPAT1281
SPAT
Other administrative function
1.4
11.5
623
4608
M070, L400
ICD-10 Finland
NA
+∞
11.5
11
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.4
11.4
521
3735
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.6
11.4
283
1776
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.3
11.4
695
5235
C09AA05
ATC
ramipril; oral
1.2
11.4
1981
16959
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
1.6
11.4
289
1825
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.5
11.4
368
2462
M06.4
ICD-10 Finland
Inflammatory polyarthropathy
3.7
11.4
48
130
Z71.9
ICD-10 Finland
Counselling, unspecified
1.5
11.4
425
2932
M04AA03
ATC
febuxostat; oral
4.1
11.3
43
106
SPAT1211
SPAT
Application of soft bandage
1.3
11.3
701
5292
H20.1
ICD-10 Finland
Chronic iridocyclitis
2.3
11.3
100
435
L01CB
ATC
Podophyllotoxin derivatives
5.2
11.3
34
66
H29
ICPC
Ear symptom/complaint other
1.3
11.3
755
5767
349
Kela drug reimbursment
Febuxostat
4.2
11.3
41
97
R03AC03
ATC
terbutaline; inhalant
1.3
11.3
1141
9222
Z01.2
ICD-10 Finland
Dental examination
1.2
11.3
3794
34317
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.0
11.2
147
753
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.3
11.2
781
6008
M01AE52
ATC
naproxen and esomeprazole; oral
1.6
11.2
267
1661
R1250
NOMESCO Finland
Evaluation of functional capability
1.9
11.2
171
929
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.3
11.1
805
6222
R31
ICD-10 Finland
Unspecified haematuria
1.3
11.1
741
5659
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.5
11.1
375
2536
TQW11
NOMESCO Finland
Vacuum treatment of wound
1.9
11.1
150
780
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.4
11.0
625
4658
C01DA14
ATC
isosorbide mononitrate; oral
1.3
10.9
1013
8097
A01AB09
ATC
miconazole; local oral
1.4
10.9
653
4903
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
2.1
10.9
115
541
H03AA01
ATC
levothyroxine sodium; systemic
1.2
10.9
1932
16572
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.7
10.9
236
1433
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.3
10.9
691
5239
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
2.2
10.8
107
489
M02AA10
ATC
ketoprofen; topical
1.2
10.8
1312
10830
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
3.5
10.7
49
142
L43.1
ICD-10 Finland
Bullous lichen planus
60.0
10.6
12
*
SGC10
NOMESCO Finland
Covering pulpa of tooth
1.3
10.6
732
5619
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.6
10.6
298
1932
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
1.9
10.6
147
774
C08CA13
ATC
lercanidipine; oral
1.3
10.6
988
7902
D11AH01
ATC
tacrolimus; topical
2.5
10.6
79
315
K02
ICD-10 Finland
Dental caries
1.4
10.6
565
4167
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
4.1
10.5
40
99
EB1WA
NOMESCO Finland
NA
2.9
10.5
63
221
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.7
10.5
217
1296
RT171
NOMESCO Finland
NA
6.0
10.5
28
47
K51.8
ICD-10 Finland
Other ulcerative colitis
2.0
10.5
124
611
EBA10
NOMESCO Finland
Surgical removal of tooth
1.3
10.5
935
7434
A60
ICPC
General and Unspecified, Result test/procedure
1.5
10.5
320
2113
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
2.1
10.5
113
539
XQ845
NOMESCO Finland
Dermatoscopy
2.2
10.5
103
472
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
2.0
10.5
137
705
S01
ICPC
Pain/tenderness of skin
1.5
10.5
312
2053
M073, L409
ICD-10 Finland
NA
+∞
10.4
10
*
UDC00
NOMESCO Finland
Ear microscopy
1.4
10.4
564
4170
TPH07
NOMESCO Finland
Cathetrisation of artery
1.3
10.4
784
6101
C09CA03
ATC
valsartan; oral
1.3
10.4
683
5206
L88
ICD-10 Finland
Pyoderma gangrenosum
5.6
10.4
29
52
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.3
10.4
752
5819
SPAT1059
SPAT
Spirometry at the office
1.4
10.3
409
2856
E66
ICD-10 Finland
Obesity
1.5
10.3
330
2204
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.2
10.3
1511
12714
L04AA44
ATC
upadacitinib; oral
16.0
10.3
16
10
M66.0
ICD-10 Finland
Rupture of popliteal cyst
2.1
10.3
108
506
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
6.4
10.3
26
41
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
2.2
10.3
103
475
N05BA12
ATC
alprazolam; oral
1.3
10.3
836
6569
A03FA01
ATC
metoclopramide; systemic, rectal
1.2
10.3
1734
14797
C07AA05
ATC
propranolol; systemic
1.2
10.3
1615
13688
M77.9
ICD-10 Finland
Enthesopathy, unspecified
1.7
10.2
218
1317
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.6
10.2
273
1748
M01AB08
ATC
etodolac; oral
1.4
10.2
601
4505
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
1.6
10.2
284
1836
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.2
10.2
1576
13330
K92.1
ICD-10 Finland
Melaena
1.5
10.2
358
2439
S74
ICPC
Dermatophytosis
1.9
10.2
145
771
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.4
10.2
398
2774
J01FA15
ATC
telithromycin; oral
1.3
10.2
850
6706
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
1.8
10.2
161
889
RJ511
NOMESCO Finland
NA
4.9
10.2
32
66
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
1.9
10.1
134
691
H60.1
ICD-10 Finland
Cellulitis of external ear
2.2
10.1
100
460
R03BA01
ATC
beclometasone; inhalant
1.2
10.1
1147
9390
UKC02
NOMESCO Finland
Cystoscopy
1.2
10.1
1233
10180
M02.3
ICD-10 Finland
Reiter disease
5.9
10.1
27
46
TNF11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in hip joint
5.4
10.1
29
54
P74
ICPC
Anxiety disorder/anxiety state
1.6
10.1
249
1565
J45.8
ICD-10 Finland
Mixed asthma
1.6
10.0
224
1370
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
1.7
10.0
200
1185
L23.1
ICD-10 Finland
Allergic contact dermatitis due to adhesives
3.6
10.0
43
119
J01CR50
ATC
combinations of penicillins; systemic
4.5
10.0
34
76
Z01.9
ICD-10 Finland
Special examination, unspecified
1.4
10.0
420
2967
A10BX04
ATC
[U] exenatide; parenteral
2.3
10.0
90
394
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
1.8
10.0
153
833
M25.9
ICD-10 Finland
Joint disorder, unspecified
2.3
10.0
85
365
WQ055
NOMESCO Finland
NA
40.0
10.0
12
*
M54.2
ICD-10 Finland
Cervicalgia
1.4
9.9
551
4092
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.4
9.9
560
4174
C09BA02
ATC
enalapril and diuretics; systemic
1.3
9.9
619
4688
R06.5
ICD-10 Finland
Mouth breathing
1.3
9.8
719
5568
C09DA01
ATC
losartan and diuretics; oral
1.3
9.8
807
6350
L86
ICPC
Back syndrome with radiating pain
1.4
9.8
425
3023
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
9.8
2784
24810
S22.3
ICD-10 Finland
Fracture of rib
1.4
9.8
500
3661
L04AC07
ATC
tocilizumab; parenteral
4.1
9.8
36
87
H70
ICPC
Otitis externa
1.8
9.8
160
894
A10BX01
ATC
guar gum; systemic
1.6
9.7
250
1587
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
9.7
1706
14610
B37.2
ICD-10 Finland
Candidiasis of skin and nail
2.8
9.7
61
220
R07.3
ICD-10 Finland
Other chest pain
1.3
9.7
708
5486
R01AD12
ATC
fluticasone furoate; nasal
1.2
9.7
2609
23159
SPAT1240
SPAT
Therapeutic discussion
1.3
9.6
817
6457
F34.1
ICD-10 Finland
Dysthymia
1.6
9.6
264
1705
L41.0
ICD-10 Finland
Pityriasis lichenoides et varioliformis acuta
55.0
9.6
11
*
QDH05
NOMESCO Finland
Correction of deformity of toe nail
3.6
9.6
41
113
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
3.3
9.6
46
139
L70.0
ICD-10 Finland
Acne vulgaris
1.8
9.6
147
803
E87.6
ICD-10 Finland
Hypokalaemia
1.6
9.6
218
1342
N07BB01
ATC
disulfiram; oral
1.5
9.6
369
2564
NDG30
NOMESCO Finland
Fusion of wrist, total
2.9
9.6
56
194
SBA00
NOMESCO Finland
Microbiological examinations
1.8
9.6
169
968
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.5
9.6
295
1955
K02.2
ICD-10 Finland
Caries of cementum
1.5
9.5
325
2204
B35.2
ICD-10 Finland
Tinea manuum
4.5
9.5
32
71
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
1.7
9.5
190
1128
C08CA02
ATC
felodipine; oral
1.3
9.5
666
5128
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.5
9.5
336
2296
H62.0*A46
ICD-10 Finland
Otitis externa in erysipelas
2.5
9.5
69
273
WX722
NOMESCO Finland
PEEP
1.5
9.5
365
2539
L34
ICPC
Musculoskeletal, Blood test
7.1
9.5
22
31
RJ410
NOMESCO Finland
NA
3.3
9.5
46
141
SPAT1252
SPAT
Overall medication plan or its review
1.4
9.4
496
3650
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
2.7
9.4
61
226
L04
ICPC
Chest symptom/complaint
1.4
9.4
419
2994
L41.8
ICD-10 Finland
Other parapsoriasis
100.1
9.4
10
*
R2110
NOMESCO Finland
Giving the first information
1.4
9.4
537
4009
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.7
9.4
173
1005
69610
ICD-8 Finland
Psoriasis and similar disorders, Psoriasis pustulosa
+∞
9.4
9
*
6961B
ICD-9 Finland
Psoriasis and similar disorders, Other psoriasis[PSORIASIS PUSTULARIS]
+∞
9.4
9
*
M075, L405
ICD-10 Finland
NA
+∞
9.4
9
*
L41.4
ICD-10 Finland
Large plaque parapsoriasis
+∞
9.4
9
*
RS224
NOMESCO Finland
NA
3.3
9.4
45
137
L50.0
ICD-10 Finland
Allergic urticaria
1.7
9.3
185
1097
R13
ICD-10 Finland
Dysphagia
1.4
9.3
470
3434
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
1.9
9.3
124
645
NHG20
NOMESCO Finland
Fusion of talocrural joint
2.7
9.3
60
222
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
2.3
9.3
80
345
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.3
9.3
744
5835
F41.09
ICD-10 Finland
UNS Panic Syndrome
1.7
9.3
196
1183
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.3
9.3
655
5048
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.4
9.2
489
3604
ND1AE
NOMESCO Finland
Wrist ultrasound examination
3.3
9.2
44
133
H13
ICPC
Plugged feeling ear
1.2
9.2
1390
11725
J01DC02
ATC
cefuroxime; systemic
1.4
9.2
444
3219
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
1.6
9.2
240
1528
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
1.7
9.2
187
1115
A99
ICPC
Disease/condition unspecnature/site
1.3
9.2
586
4449
L30.1
ICD-10 Finland
Dyshidrosis [pompholyx]
3.1
9.2
49
161
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
9.2
2903
26060
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.2
9.1
1731
14914
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
1.8
9.1
161
919
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.7
9.1
193
1165
S02
ICPC
Pruritus
1.6
9.1
226
1423
H60
ICD-10 Finland
Otitis externa
1.5
9.1
347
2407
A10BB01
ATC
glibenclamide; oral
1.6
9.1
237
1513
-62
ICPC
Administrative procedure
1.6
9.1
206
1268
R5599
NOMESCO Finland
Other rehabilitation service
1.6
9.1
206
1268
L30
ICD-10 Finland
Other dermatitis
1.8
9.1
138
753
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
1.6
9.1
201
1231
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.6
9.0
246
1585
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.5
9.0
263
1721
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
9.0
1423
12055
C10AA07
ATC
rosuvastatin; oral
1.2
9.0
2013
17592
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
1.6
9.0
225
1420
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
1.6
9.0
222
1398
R03DA04
ATC
theophylline; systemic, rectal
1.5
9.0
343
2384
M54.3
ICD-10 Finland
Sciatica
1.4
9.0
446
3251
D82
ICPC
Teeth/gum disease
1.1
9.0
3088
27873
A10BH05
ATC
linagliptin; oral
1.5
9.0
315
2151
NHG22
NOMESCO Finland
Fusion of subtalar joint
2.5
9.0
65
256
D01AC08
ATC
ketoconazole; topical
2.0
9.0
112
568
M79.1
ICD-10 Finland
Myalgia
1.2
8.9
993
8112
R20.2
ICD-10 Finland
Paraesthesia of skin
1.4
8.9
487
3609
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
1.3
8.9
889
7169
F10.20
ICD-10 Finland
Alcohol dependence currently independent
1.7
8.9
165
959
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
1.6
8.9
206
1273
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
8.9
1329
11199
S20
ICPC
Corn/callosity
1.8
8.9
148
830
R03DC03
ATC
montelukast; oral
1.2
8.9
1295
10884
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.2
8.9
1278
10730
M46.8
ICD-10 Finland
Other specified inflammatory spondylopathies
5.7
8.9
24
42
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.3
8.8
571
4344
K04.08
ICD-10 Finland
Other specified pulpit
1.4
8.8
492
3657
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
2.5
8.8
65
260
M54.6
ICD-10 Finland
Pain in thoracic spine
1.4
8.8
509
3808
M01AC01
ATC
piroxicam; systemic, rectal
1.2
8.8
1084
8953
RJ190
NOMESCO Finland
NA
4.0
8.8
33
82
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
8.8
195
1196
SPAT1104
SPAT
Monitoring of emergency patient
1.4
8.8
499
3721
N06AX12
ATC
bupropion; oral
1.4
8.8
452
3317
JN3AD
NOMESCO Finland
Abdominal CT examination
1.3
8.7
594
4555
-43
ICPC
Other diagnostic procedure
1.9
8.7
119
624
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
5.3
8.7
25
47
J04BA02
ATC
dapsone; oral
2.9
8.7
50
170
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.5
8.7
300
2041
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.3
8.7
592
4539
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.3
8.7
583
4463
L02
ICPC
Back symptom/complaint
1.3
8.7
672
5248
ECA20
NOMESCO Finland
Biopsy of gingiva
2.3
8.7
79
351
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
1.7
8.7
175
1045
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
3.3
8.7
41
124
F03
ICPC
Eye discharge
1.4
8.6
433
3165
F10.25
ICD-10 Finland
Alcohol dependence continuous use
1.8
8.6
144
811
D01
ICPC
Abdominal pain/cramps general
1.3
8.6
780
6216
Y94.0
ICD-10 Finland
Accident at home
1.9
8.6
124
663
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
2.1
8.6
91
432
27799
ICD-8 Finland
Obesity not specified as of endocrine origin
2.5
8.6
61
240
UJD02
NOMESCO Finland
Gastroscopy
1.4
8.6
349
2458
I50.0
ICD-10 Finland
Congestive heart failure
1.4
8.6
414
3008
RJ422
NOMESCO Finland
NA
5.5
8.6
24
44
D69.0
ICD-10 Finland
Allergic purpura
2.7
8.6
56
210
WX204
NOMESCO Finland
Axillary plexus blockaced
1.6
8.6
236
1529
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
2.1
8.5
89
422
WQ022
NOMESCO Finland
NA
16.3
8.5
13
8
H66.9
ICD-10 Finland
Otitis media, unspecified
1.4
8.5
382
2738
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
1.6
8.5
192
1182
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
1.4
8.5
373
2660
D01AA02
ATC
natamycin; topical
1.7
8.5
159
927
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
1.9
8.5
125
674
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.4
8.5
403
2921
A07DA03
ATC
loperamide; oral
1.5
8.4
264
1761
T74.1
ICD-10 Finland
Physical abuse
1.8
8.4
135
752
B07.9
ICD-10 Finland
Verruca simplex
1.5
8.4
250
1645
R06AX13
ATC
loratadine; oral
1.2
8.4
1223
10275
9522
FHL
Synovectomy
4.1
8.4
31
76
G56.2
ICD-10 Finland
Lesion of ulnar nerve
1.5
8.4
247
1625
M10
ICD-10 Finland
Gout
1.5
8.4
308
2124
RJ412
NOMESCO Finland
NA
4.7
8.4
27
58
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.3
8.4
723
5732
QBA10
NOMESCO Finland
Incision of skin of trunk
2.1
8.3
92
446
R11
ICD-10 Finland
Nausea and vomiting
1.3
8.3
560
4287
F43.1
ICD-10 Finland
Post-traumatic stress disorder
1.7
8.3
156
912
C02AC05
ATC
moxonidine; oral
1.5
8.3
317
2202
L400, L405
ICD-10 Finland
NA
+∞
8.3
8
*
M076, L405
ICD-10 Finland
NA
+∞
8.3
8
*
M073, M405
ICD-10 Finland
NA
+∞
8.3
8
*
6960A
ICD-10 Finland
NA
+∞
8.3
8
*
L29.9
ICD-10 Finland
Pruritus, unspecified
1.7
8.3
161
951
M54.1
ICD-10 Finland
Radiculopathy
1.5
8.3
286
1950
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
1.7
8.2
179
1090
B02.9
ICD-10 Finland
Zoster without complication
1.4
8.2
390
2825
Z00.0
ICD-10 Finland
General medical examination
1.2
8.2
1500
12880
9503
FHL
Tendon or tendon sheath cleansing surgery (tenosynovectomy)
3.5
8.2
36
103
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
1.6
8.2
224
1447
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.4
8.2
422
3100
XQ801
NOMESCO Finland
Intracutantest
3.3
8.2
39
119
J01XC01
ATC
fusidic acid; systemic
2.0
8.2
104
534
EKA10
NOMESCO Finland
Biopsy of cheek
1.8
8.2
134
752
F10.09
ICD-10 Finland
Alcohol intoxication UNS
1.7
8.2
168
1009
A07EA02
ATC
hydrocortisone; rectal
1.6
8.1
178
1086
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.2
8.1
875
7123
A04
ICPC
Weakness/tiredness general
1.2
8.1
917
7504
H57.1
ICD-10 Finland
Ocular pain
1.5
8.1
231
1507
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.6
8.1
220
1420
M05.3
ICD-10 Finland
Rheumatoid arthritis with involvement of other organs and systems
5.6
8.1
22
39
B35.1
ICD-10 Finland
Tinea unguium
1.4
8.1
414
3038
S04
ICPC
Lump/swelling localized
1.3
8.1
671
5291
A08
ICPC
Swelling
1.5
8.1
285
1951
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
1.7
8.1
164
981
9256
FHL
Synovectomy (knee 9311)
4.3
8.1
28
65
J45
ICD-10 Finland
Asthma
1.3
8.1
740
5911
SPAT1204
SPAT
Arthrocentesis
2.3
8.1
67
287
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
3.2
8.1
40
126
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.5
8.0
297
2051
A02BA04
ATC
nizatidine; systemic
1.3
8.0
571
4408
L73.8
ICD-10 Finland
Other specified follicular disorders
2.2
8.0
75
340
WXQ20
NOMESCO Finland
UVA broad spectrum light therapy
22.0
8.0
11
5
N19
ICD-10 Finland
Unspecified kidney failure
1.6
8.0
203
1291
C08DB01
ATC
diltiazem; oral
1.4
8.0
328
2313
R01AD08
ATC
fluticasone; nasal
1.1
8.0
2497
22368
HAHOM
NOMESCO Finland
NA
2.0
8.0
91
446
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.2
8.0
851
6922
F32
ICD-10 Finland
Depressive episode
1.4
8.0
378
2739
SPAT1058
SPAT
PEF monitoring instruction
1.3
8.0
612
4775
P01BA01
ATC
chloroquine; systemic
2.8
7.9
47
166
R81
ICPC
Pneumonia
1.5
7.9
223
1452
B35.4
ICD-10 Finland
Tinea corporis
2.1
7.9
84
400
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
2.1
7.9
80
375
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.2
7.9
952
7844
NH1AD
NOMESCO Finland
Ankle and foot CT
1.7
7.9
159
949
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
2.6
7.9
55
213
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
1.4
7.9
348
2485
PAW37
NOMESCO Finland
Biopsy of temporal artery
2.6
7.9
55
214
S06.0
ICD-10 Finland
Concussion
1.3
7.9
774
6233
K05.3
ICD-10 Finland
Chronic periodontitis
1.4
7.9
389
2838
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
1.8
7.9
122
673
4AB0X
NOMESCO Finland
NA
13.0
7.9
13
10
WX110
SPAT
NA
1.4
7.8
343
2447
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
1.9
7.8
108
572
SPAT1336
SPAT
Request for examination
1.5
7.8
267
1813
N02AC04
ATC
dextropropoxyphene; oral
1.5
7.8
246
1642
M05BA01
ATC
etidronic acid; systemic
3.2
7.8
38
118
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.3
7.8
757
6087
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
1.7
7.8
163
982
D06
ICPC
Abdominal pain localized other
1.3
7.8
580
4506
4AB0M
NOMESCO Finland
NA
10.8
7.8
14
13
N48.1
ICD-10 Finland
Balanoposthitis
1.7
7.8
163
987
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
2.3
7.8
67
291
RS211
NOMESCO Finland
NA
3.3
7.8
36
108
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.5
7.8
285
1966
E66.0
ICD-10 Finland
Obesity due to excess calories
2.1
7.7
83
400
F10.24
ICD-10 Finland
Alcohol depence active use
1.8
7.7
117
642
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
2.1
7.7
85
414
N05CF02
ATC
zolpidem; oral
1.2
7.7
1463
12608
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
1.6
7.7
180
1123
A12BA01
ATC
potassium chloride; oral
1.5
7.7
256
1735
C10AB05
ATC
fenofibrate; oral
1.7
7.6
137
792
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
2.0
7.6
87
430
M76.6
ICD-10 Finland
Achilles tendinitis
1.4
7.6
344
2472
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
1.8
7.6
122
682
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.3
7.6
532
4100
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.3
7.6
707
5656
A01AB04
ATC
amphotericin B; local oral
1.4
7.6
320
2272
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.5
7.6
255
1729
K30
ICD-10 Finland
Functional dyspepsia
1.2
7.6
798
6483
L43.2
ICD-10 Finland
Lichenoid drug reaction
25.0
7.6
10
*
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
1.9
7.5
97
501
D94
ICPC
Chronic enteritis/ulcerative colitis
2.5
7.5
56
225
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
1.7
7.5
155
931
1220
FHL
Arthroscopy
1.4
7.5
302
2121
SPAT1097
SPAT
Recording of ECG
1.2
7.5
1143
9647
K10.3
ICD-10 Finland
Alveolitis of jaws
1.4
7.5
319
2266
S01.0
ICD-10 Finland
Open wound of scalp
1.3
7.5
543
4203
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
2.6
7.5
50
191
L71.0
ICD-10 Finland
Perioral dermatitis
2.0
7.5
92
465
R06AX18
ATC
acrivastine; oral
1.5
7.5
207
1344
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.3
7.5
621
4898
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
1.8
7.5
119
664
A29
ICPC
General symptom/complaint other
1.2
7.5
808
6582
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
1.6
7.5
163
997
D07AB09
ATC
triamcinolone; topical
2.6
7.5
52
202
M54
ICD-10 Finland
Dorsalgia
1.2
7.5
858
7036
R03AC12
ATC
salmeterol; inhalant
1.4
7.5
311
2202
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.2
7.5
805
6556
L50.9
ICD-10 Finland
Urticaria, unspecified
1.5
7.4
243
1639
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.2
7.4
1352
11598
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.3
7.4
710
5702
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.5
7.4
262
1798
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
2.2
7.4
68
306
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.2
7.4
1731
15169
7165A
ICD-9 Finland
Other and unspecified arthropathies, Unspecified polyarthropathy or polyarthritis
6.4
7.4
18
28
K11.2
ICD-10 Finland
Sialoadenitis
1.5
7.4
224
1487
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.4
7.4
357
2599
K70.4
ICD-10 Finland
Alcoholic hepatic failure
2.9
7.4
43
151
RJ512
NOMESCO Finland
NA
4.5
7.4
24
53
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
1.7
7.3
129
743
L13
ICPC
Hip symptom/complaint
1.2
7.3
1158
9807
R5120
NOMESCO Finland
Preparation of an aid
1.6
7.3
175
1097
C01CA24
ATC
epinephrine; parenteral
1.3
7.3
434
3262
L20.8
ICD-10 Finland
Other atopic dermatitis
2.1
7.3
77
367
8511
FHL
Cervical dilation and drainage with suction
1.5
7.3
231
1548
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
1.5
7.3
214
1407
Z22.30
ICD-10 Finland
Latent tuberculosis
8.3
7.3
15
18
WW200
SPAT
NA
0.8
7.3
547
6874
A10BD07
ATC
metformin and sitagliptin; systemic
1.4
7.3
313
2229
L04AC12
ATC
brodalumab; systemic
+∞
7.3
7
*
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
1.7
7.3
141
836
K07
ICPC
Swollen ankles/oedema
1.4
7.3
276
1920
K50
ICD-10 Finland
Crohn disease [regional enteritis]
3.2
7.3
36
114
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
2.2
7.3
69
314
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
1.6
7.3
156
951
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
1.8
7.3
119
671
KA1AE
NOMESCO Finland
Kidney ultrasound examination
1.6
7.3
169
1051
K61.0
ICD-10 Finland
Anal abscess
1.8
7.2
124
707
S24
ICPC
Hair/scalp symptom/complaint other
2.3
7.2
66
294
ND1BG
NOMESCO Finland
Wrist and hand MRI examination with high intensity magnet
2.0
7.2
86
432
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
1.5
7.2
219
1452
L50.3
ICD-10 Finland
Dermatographic urticaria
1.8
7.2
114
632
KGH10
NOMESCO Finland
Operation for phimosis
1.6
7.2
185
1183
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
1.7
7.2
136
798
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.5
7.2
202
1318
H25.8
ICD-10 Finland
Other senile cataract
1.3
7.2
657
5248
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.2
7.2
976
8150
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.2
7.2
1652
14455
177
Kela drug reimbursment
Insulin glargine 300 U / ml
1.7
7.2
150
909
RS230
NOMESCO Finland
NA
2.6
7.1
48
185
N01
ICPC
Headache
1.3
7.1
704
5674
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
1.6
7.1
189
1217
RF120
NOMESCO Finland
NA
2.0
7.1
83
414
RF420
NOMESCO Finland
NA
1.9
7.1
102
549
-50
ICPC
Medication/prescr/renewal
1.4
7.1
291
2054
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
2.0
7.1
87
441
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
1.7
7.1
146
880
M05BA07
ATC
risedronic acid; oral
1.6
7.1
190
1224
A62
ICPC
General and Unspecified, Administrative procedure
1.6
7.1
171
1077
A10BG03
ATC
pioglitazone; oral
1.6
7.1
179
1140
L44.8
ICD-10 Finland
Other specified papulosquamous disorders
7.9
7.1
15
19
HMAK
NOMESCO Finland
NA
1.2
7.1
962
8030
J04AB02
ATC
rifampicin; systemic
1.9
7.1
91
470
Z25.1
ICD-10 Finland
Need for immunization against influenza
1.4
7.1
389
2894
S19
ICPC
Skin injury other
1.5
7.1
262
1817
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.3
7.1
488
3759
F01
ICPC
Eye pain
1.6
7.0
183
1171
B81
ICPC
Anaemia vit B12/folate deficiency
1.5
7.0
244
1668
OAB50
SPAT
NA
1.8
7.0
107
587
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
1.7
7.0
147
890
WX203
NOMESCO Finland
Infraclavicular plexus blockade
1.6
7.0
178
1131
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
2.1
7.0
75
361
P15
ICPC
Chronic alcohol abuse
1.5
7.0
211
1401
NDF60
NOMESCO Finland
Operation for osteochondritis of a joint of hand,v
3.1
7.0
35
112
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
1.7
7.0
122
701
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.4
7.0
346
2529
B82
ICPC
Anaemia other/unspecified
1.6
7.0
158
976
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
1.7
7.0
125
722
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.2
7.0
1167
9940
NDG77
NOMESCO Finland
Other excision, reconstruction or fusion of joint of first finger
3.4
7.0
31
91
K59.09
ICD-10 Finland
Constipation, unspecified
1.4
7.0
390
2911
R29
ICPC
Respiratory symptom/complaint other
1.3
7.0
454
3467
PE1AT
NOMESCO Finland
Femoral artery PTA
2.0
7.0
79
389
S94
ICPC
Ingrowing nail
1.8
6.9
108
596
ZX114
NOMESCO Finland
Intramuscular
1.8
6.9
108
600
K70.1
ICD-10 Finland
Alcoholic hepatitis
2.3
6.9
59
258
NA6BM
NOMESCO Finland
Sacro-iliac joint MRI examination with 3 Tesla magnet
5.8
6.9
18
31
RT310
NOMESCO Finland
NA
5.8
6.9
18
31
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
2.2
6.9
62
278
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.1
6.9
2137
19112
L50.8
ICD-10 Finland
Other urticaria
1.7
6.9
128
750
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
2.0
6.9
85
432
K56.7
ICD-10 Finland
Ileus, unspecified
1.8
6.9
106
587
R07
ICPC
Sneezing/nasal congestion
1.3
6.9
433
3288
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.2
6.9
1558
13614
K29.7
ICD-10 Finland
Gastritis, unspecified
1.5
6.9
246
1694
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
1.4
6.8
322
2333
S86
ICPC
Dermatitis seborrhoeic
2.9
6.8
38
131
L60.3
ICD-10 Finland
Nail dystrophy
2.9
6.8
38
131
B99
ICD-10 Finland
Other and unspecified infectious diseases
1.7
6.8
138
827
R5110
SPAT
NA
1.6
6.8
170
1080
Z02.7
ICD-10 Finland
Issue of medical certificate
1.3
6.8
426
3232
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.2
6.8
752
6139
F32.1
ICD-10 Finland
Moderate depressive episode
1.4
6.8
373
2773
EB1AA
SPAT
NA
1.4
6.8
346
2539
O99.7
ICD-10 Finland
Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium
4.8
6.8
21
44
RK220
NOMESCO Finland
NA
3.1
6.8
34
109
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.5
6.8
204
1354
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
1.7
6.8
136
813
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
1.8
6.8
111
626
Z72.1
ICD-10 Finland
Alcohol use
1.9
6.8
95
507
P01
ICPC
Feeling anxious/nervous/tense
1.2
6.8
700
5677
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
1.7
6.7
118
681
K71
ICPC
Rheumatic fever/heart disease
5.6
6.7
18
32
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
1.6
6.7
144
880
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
2.1
6.7
66
308
RS311
NOMESCO Finland
NA
3.3
6.7
31
94
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
1.7
6.7
121
703
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.4
6.7
298
2140
G43.9
ICD-10 Finland
Migraine, unspecified
1.4
6.7
370
2757
WX723
NOMESCO Finland
CPAP therapy
1.4
6.7
270
1905
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
1.6
6.7
179
1155
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.4
6.7
348
2568
M07.6
ICD-10 Finland
Other enteropathic arthropathies
22.5
6.7
9
*
SPAT1147
SPAT
Destruction of skin lesion with external methods
1.7
6.7
124
727
9311
FHL
Knee cleansing surgery (synovectomy, debridement)
3.5
6.6
28
79
358
Kela drug reimbursment
liraglutide
2.5
6.6
48
193
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.3
6.6
530
4164
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.7
6.6
138
837
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.3
6.6
416
3160
M01AH03
ATC
valdecoxib; oral
1.3
6.6
489
3801
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.3
6.6
379
2841
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.4
6.6
339
2497
R80
ICD-10 Finland
Isolated proteinuria
2.2
6.6
62
283
F29
ICPC
Eye symptom/complaint other
1.3
6.6
580
4616
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
2.2
6.6
60
272
N06AB06
ATC
sertraline; oral
1.2
6.6
827
6856
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.4
6.5
358
2661
J37.0
ICD-10 Finland
Chronic laryngitis
1.5
6.5
226
1547
B01AA03
ATC
warfarin; systemic
1.2
6.5
1406
12235
SPAT1251
SPAT
Organisation of medication
1.5
6.5
233
1603
R04.0
ICD-10 Finland
Epistaxis
1.3
6.5
486
3782
WX212
NOMESCO Finland
Femoral plexus blockade
1.7
6.5
123
727
R10.0
ICD-10 Finland
Acute abdomen
1.5
6.5
215
1457
L27.1
ICD-10 Finland
Localized skin eruption due to drugs and medicaments
2.7
6.5
42
157
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
1.8
6.5
100
553
N06AB08
ATC
fluvoxamine; oral
1.5
6.5
204
1368
NA3BM
NOMESCO Finland
Lumbar spine MRI examination with 3 Tesla magnet
2.8
6.5
39
142
L24.9
ICD-10 Finland
Irritant contact dermatitis, unspecified cause
2.6
6.4
43
166
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
1.7
6.4
129
775
J46
ICD-10 Finland
Status asthmaticus
1.5
6.4
190
1256
H02BX01
ATC
methylprednisolone, combinations; systemic
1.3
6.4
364
2722
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
1.9
6.4
88
468
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
1.6
6.4
157
991
T78.3
ICD-10 Finland
Angioneurotic oedema
1.8
6.4
96
527
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.3
6.4
411
3134
A63.0
ICD-10 Finland
Anogenital (venereal) warts
1.4
6.4
240
1668
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
1.5
6.4
227
1561
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
3.0
6.4
33
109
M16.7
ICD-10 Finland
Other secondary coxarthrosis
2.1
6.4
63
294
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
1.4
6.4
345
2564
L05
ICPC
Flank/axilla symptom/complaint
1.3
6.4
374
2814
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.2
6.4
805
6676
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
1.6
6.3
166
1069
SPAT1342
SPAT
Referral to specialised care
1.9
6.3
85
447
SPAT1070
SPAT
Doppler ultrasound examination of blood flow in arteries of lower extremity
1.7
6.3
114
663
E000005
ATC
NA
4.9
6.3
19
39
P29
ICPC
Psychological sympt/compl other
1.3
6.3
385
2910
298
Kela drug reimbursment
NA
8.1
6.3
13
16
K60.3
ICD-10 Finland
Anal fistula
1.7
6.3
131
792
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.4
6.3
266
1895
F51.0
ICD-10 Finland
Nonorganic insomnia
1.2
6.3
971
8210
K92.0
ICD-10 Finland
Haematemesis
1.6
6.3
156
991
OAB72
NOMESCO Finland
Weight control and weight loss guidance
2.4
6.3
48
197
5551A
ICD-9 Finland
Regional enteritis, Large intestine
5.9
6.3
16
27
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
1.6
6.3
136
835
NHG82
NOMESCO Finland
Fusion of other tarsal joint
2.0
6.3
70
346
D05BA02
ATC
methoxsalen; oral
18.0
6.3
9
5
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.4
6.3
301
2191
M073, K519
ICD-10 Finland
NA
+∞
6.2
6
*
69621
ICD-8 Finland
Psoriasis and similar disorders, Parapsoriasis guttata
+∞
6.2
6
*
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
1.8
6.2
106
607
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
1.5
6.2
194
1299
R04.2
ICD-10 Finland
Haemoptysis
1.5
6.2
222
1529
L20
ICD-10 Finland
Atopic dermatitis
1.6
6.2
152
963
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.4
6.2
245
1723
C07AG02
ATC
carvedilol; oral
1.3
6.2
396
3018
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.3
6.2
423
3254
L89
ICD-10 Finland
Decubitus ulcer and pressure area
1.8
6.2
103
584
XX9XT
NOMESCO Finland
Other radiological intervention
6.3
6.1
15
24
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
2.0
6.1
75
382
XF402
NOMESCO Finland
ECG with work load test
1.2
6.1
830
6930
WX780
NOMESCO Finland
Remote monitoring CPAP
1.4
6.1
295
2151
ZQZ00
NOMESCO Finland
Treatment of several skin areas
2.6
6.1
41
159
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.4
6.1
291
2119
L01.1
ICD-10 Finland
Impetiginization of other dermatoses
2.6
6.1
40
152
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.4
6.1
335
2497
N03AF01
ATC
carbamazepine; oral, rectal
1.3
6.1
356
2680
SPAT1146
SPAT
Puncture of abscess or incision of skin
1.6
6.1
132
809
NGF10
NOMESCO Finland
Total synovectomy of knee, open
4.0
6.1
22
55
N05AN01
ATC
lithium; oral
1.5
6.1
174
1147
M65.8
ICD-10 Finland
Other synovitis and tenosynovitis
1.6
6.1
155
993
NHL50
NOMESCO Finland
Tenolysis or tenosynovectomy of foot
2.6
6.1
40
153
Z46.7
ICD-10 Finland
Fitting and adjustment of orthopaedic device
3.6
6.1
25
70
3006
Kela drug reimbursment
Baricitinib
3.6
6.1
25
70
N03AX09
ATC
lamotrigine; oral
1.4
6.1
333
2479
ECB00
NOMESCO Finland
Suture of gingiva
1.4
6.0
254
1810
TUPKY
NOMESCO Finland
NA
2.1
6.0
63
302
A02BX02
ATC
sucralfate; oral
1.4
6.0
276
1995
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
1.5
6.0
184
1227
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
1.8
6.0
100
566
L72.1
ICD-10 Finland
Trichilemmal cyst
1.3
6.0
448
3489
H16.9
ICD-10 Finland
Keratitis, unspecified
1.7
6.0
111
652
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.2
6.0
820
6855
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021589) Normoblasts [#/volume] in Blood
7328
47528
2.22
307.65
14.3
9.3
e9/l
0.0
0.0
1.43
6424
38737
(3019069) Monocytes/100 leukocytes in Blood
8661
50460
3.08
307.65
11.7
6.2
%
8.8
8.6
7.34
8401
47191
(40760892) CBC W Ordered Manual Differential panel - Blood
4334
24006
2.20
307.65
7.2
4.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
9354
55140
3.38
307.65
11.0
5.8
e9/l
2.0
1.9
1.77
8694
48488
(3013707) Erythrocyte sedimentation rate by Westergren method
10559
80062
2.58
307.65
6.9
3.9
mm/h
13.1
11.7
21.11
10071
74360
(3017181) Myelocytes/100 leukocytes in Blood
2284
8857
2.91
307.65
5.2
4.1
%
0.6
1.0
8.62
524
2561
(40768443) Skin Pathology biopsy report
1394
4434
3.40
307.65
1.3
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
8730
51916
3.01
307.65
11.5
6.0
%
28.4
28.1
2.45
8458
48298
(3006315) Basophils [#/volume] in Blood
9290
53734
3.45
307.65
10.9
5.7
e9/l
0.0
0.0
25.70
8551
46323
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
1578
3092
5.66
307.65
1.6
1.6
iu/ml
0.2
8.1
0.91
277
697
(3006504) Eosinophils/100 leukocytes in Blood
8649
50189
3.09
307.65
11.3
5.9
%
2.9
2.9
1.98
8368
46690
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
10776
83348
2.58
307.65
10.2
7.5
u/l
78.6
77.7
1.23
10392
78606
(3025159) Blasts/100 leukocytes in Blood
2141
7935
3.03
307.65
5.3
4.1
%
0.2
0.2
0.00
441
2003
(3018010) Neutrophils/100 leukocytes in Blood
8659
51121
3.01
307.65
11.1
5.8
%
57.1
57.1
0.05
8390
47760
(3021440) Promyelocytes/100 leukocytes in Blood
2217
8422
2.96
307.65
5.3
4.1
%
0.0
0.1
5.48
495
2378
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
3527
18507
2.24
307.65
1.3
1.3
iu/ml
47.3
32.7
0.68
976
5827
(3013650) Neutrophils [#/volume] in Blood by Automated count
9770
62129
3.19
307.65
13.6
9.1
e9/l
4.1
4.1
0.71
9008
54107
(3022096) Basophils/100 leukocytes in Blood
8527
48636
3.12
307.65
11.3
6.0
%
0.7
0.7
21.89
8251
45284
(3001604) Monocytes [#/volume] in Blood
9263
53512
3.44
307.65
10.9
5.7
e9/l
0.6
0.6
14.23
8517
46125
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
3504
17429
2.37
307.65
1.3
1.3
u/ml
9.1
12.6
2.47
1326
6916
(3037522) Nuclear Ab [Titer] in Serum
3336
14620
2.71
307.65
1.4
1.3
titre
417.4
517.2
2.70
630
3018
(42870588) Differential panel, method unspecified - Blood
6969
36264
2.95
307.65
10.0
5.9
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
340
215
16.20
307.65
1.5
1.5
ug/l
9.2
8.7
0.62
340
215
(3013115) Eosinophils [#/volume] in Blood
9408
55615
3.40
307.65
11.2
6.0
e9/l
0.2
0.2
5.70
8742
48750
(3002179) Metamyelocytes/100 leukocytes in Blood
2120
8069
2.94
307.65
4.8
3.9
%
0.4
0.7
5.95
406
1858
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
595
1147
5.38
292.04
1.1
1.1
iu/ml
1.6
2.1
—
9
23
(3023420) DNA double strand Ab [Units/volume] in Serum
557
1014
5.69
291.00
1.3
1.5
iu/ml
36.6
27.1
0.26
15
49
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
961
2734
3.71
286.29
1.6
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
9478
73435
2.03
278.97
5.5
4.1
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
306
299
10.45
275.31
1.6
2.1
mg/l
8.8
9.2
0.47
238
244
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1867
8035
2.54
267.51
1.3
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
2540
12616
2.25
262.80
1.5
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
1071
3589
3.16
245.36
1.1
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
2458
12430
2.20
241.26
1.5
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
7187
52338
1.82
237.04
6.0
4.7
estimate
0.0
0.0
0.08
1699
9710
(3035350) Ketones [Presence] in Urine by Test strip
7161
52176
1.81
234.91
4.4
3.5
estimate
0.0
0.0
1.28
1622
9489
(3009261) Glucose [Presence] in Urine by Test strip
7234
52878
1.81
234.66
4.5
3.5
estimate
0.0
0.0
0.03
1612
9422
(3026493) Urate [Moles/volume] in Serum or Plasma
4546
28950
1.87
231.02
2.8
2.6
umol/l
3901.2
3958.7
0.03
4011
25267
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
248
237
10.65
226.51
1.5
1.7
au/ml
241.9
100.1
2.08
35
31
(3000475) Leukocytes [#/volume] in Synovial fluid
818
2457
3.48
223.34
1.9
1.6
e6/l
8807.1
14840.5
4.30
626
1763
(40758558) Short blood count panel - Blood
4260
27306
1.83
206.94
9.7
6.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
674
1880
3.72
205.53
1.7
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
2748
15480
1.98
197.52
1.5
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
5358
37263
1.74
193.30
4.1
3.6
e6/l
74.7
90.2
0.80
3801
26401
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
500
1248
4.12
178.04
1.8
1.5
%
51.0
59.3
3.93
317
776
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5968
43675
1.67
171.52
2.6
2.2
nmol/l
75.3
76.7
3.39
5487
39578
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
411
943
4.47
163.34
1.8
1.5
%
37.0
28.9
3.44
247
576
(3044941) Cell count panel - Synovial fluid
547
1572
3.59
159.09
1.6
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
2219
12523
1.93
154.52
1.9
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
12085
109694
2.18
137.61
20.1
13.6
mg/l
19.9
23.7
37.93
10574
86456
(46235355) HIV 1 and 2 tests - Meaningful Use set
2924
18644
1.73
134.07
1.7
1.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
4446
31958
1.59
125.72
3.5
3.2
e6/l
41.3
86.2
4.72
3557
24441
(3015171) Extractable nuclear Ab [Units/volume] in Serum
936
4150
2.35
121.31
1.2
1.2
u/ml
0.5
0.9
1.19
56
395
(3026782) Osmolality of Urine
3066
20377
1.66
118.10
3.0
2.8
mosm/kgh2o
555.1
549.4
0.68
2700
17382
(3024561) Albumin [Mass/volume] in Serum or Plasma
5915
45827
1.53
116.98
5.2
5.0
g/l
35.4
35.7
4.82
5528
42650
(3042936) Bacteria identified in Isolate by Culture
2403
15079
1.73
114.43
2.3
2.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
4078
29292
1.57
112.79
3.4
3.1
e6/l
0.4
0.4
0.34
3205
21921
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
6564
52315
1.51
111.37
7.0
6.9
mmol/l
1.2
1.2
0.19
5560
44177
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
6937
56052
1.50
109.20
6.1
6.3
umol/l
10.9
11.3
2.23
6587
53234
(3000850) Epithelial cells [#/volume] in Urine
3228
22101
1.61
108.88
2.8
2.6
e6/l
5.3
5.3
0.05
2885
19339
(3023368) Bacteria identified in Blood by Culture
3915
28071
1.56
108.15
4.7
4.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
3502
24482
1.59
108.03
4.2
3.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
10341
91266
1.61
105.86
24.9
16.5
%
13.9
13.7
34.53
10232
89406
(3034891) Synovial lining cells/100 cells in Synovial fluid
234
487
4.87
104.75
1.7
1.5
%
4.8
3.3
0.67
49
113
(36304419) Bacteria [Presence] in Urine
3930
28599
1.53
99.78
3.3
3.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
3854
27934
1.54
99.65
5.0
3.9
estimate
0.0
0.0
3.83
1659
9328
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5254
40627
1.49
99.45
4.8
3.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
734
3238
2.34
95.74
1.7
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
3901
28616
1.52
94.23
4.1
3.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
186
358
5.26
91.14
2.9
3.3
mg/l
7.0
7.8
0.83
131
297
(3009871) Measles virus Ab [Titer] in Serum
190
376
5.11
90.21
1.9
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4736
36449
1.47
88.87
3.6
3.3
u/l
34.8
34.2
0.27
4465
34561
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
175
331
5.34
87.44
2.6
2.7
au/ml
151.5
138.7
0.10
25
46
(3010144) Erythrocytes [#/volume] in Synovial fluid
317
950
3.39
86.18
1.6
1.3
e6/l
45589.4
110810.3
1.63
222
648
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
99
108
9.23
82.09
1.7
1.7
mg/l
1.6
1.6
0.05
80
91
(3007164) IgA [Mass/volume] in Serum or Plasma
2918
20616
1.53
82.01
1.5
1.5
g/l
2.8
2.4
9.15
1774
12763
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3476
25526
1.49
81.03
2.5
2.2
mg/l
3.1
2.9
3.18
3026
21879
(3005719) IgG [Mass/volume] in Serum or Plasma
1389
8186
1.78
80.21
2.4
2.7
g/l
10.9
10.5
2.46
1266
7515
(3018418) pH of Serum or Plasma
4091
31106
1.46
79.52
4.2
4.2
ph
7.4
7.4
0.04
798
5996
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
11299
103679
1.62
79.39
18.4
12.6
ml/min/173m2
84.7
82.6
20.58
9813
85790
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
714
3395
2.17
77.42
1.3
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
5836
47503
1.41
77.06
6.4
6.1
mmol/l
1.2
1.2
0.04
5364
43181
(3048689) Calprotectin [Mass/mass] in Stool
2009
13203
1.62
76.86
3.0
2.3
ug/g
156.8
132.9
1.92
1645
10424
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
542
2323
2.39
75.26
1.1
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
1120
6357
1.83
73.00
1.7
1.9
g/l
1.3
1.3
0.40
1022
5831
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
3175
23428
1.47
70.44
1.3
1.3
u/ml
1.8
1.7
0.20
837
6368
(3020682) Albumin/Creatinine [Ratio] in Urine
4242
33057
1.42
69.90
4.3
4.0
mg/mmol
10.7
9.1
1.12
2786
21049
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
5251
42506
1.39
69.02
2.2
1.9
pmol/l
93.0
96.0
5.55
3023
22286
(3013826) Glucose [Moles/volume] in Serum or Plasma
7353
63000
1.38
67.55
5.1
4.7
mmol/l
6.8
6.7
3.25
6911
58942
(3022948) Iron [Moles/volume] in Serum or Plasma
2357
16549
1.52
66.31
2.7
2.6
umol/l
12.9
13.3
2.33
2195
15366
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2206
15298
1.53
65.71
2.6
2.6
g/l
2.4
2.3
1.86
2044
14190
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1244
7511
1.72
65.31
1.8
1.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
7985
69598
1.37
64.30
4.9
4.2
e6/l
904.6
1347.2
0.62
112
945
(3032080) INR in Blood by Coagulation assay
5234
42799
1.37
62.69
8.7
8.6
inr
1.3
1.2
0.19
1628
12309
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2067
14268
1.53
62.59
2.7
2.6
%
22.3
23.1
1.58
1768
12197
(3027945) Reticulocytes/100 erythrocytes in Blood
1709
11306
1.59
62.51
2.7
2.5
%
1.8
1.8
0.86
1529
10030
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
12365
117358
1.82
62.42
18.7
10.0
u/l
29.1
27.2
23.60
12166
113450
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2506
18035
1.48
61.98
2.9
2.7
e6/l
1.1
1.3
0.68
1490
10236
(3009508) Creatinine [Moles/volume] in Urine
4273
33868
1.39
61.85
3.4
3.2
mmol/l
7.7
7.8
1.07
3567
28610
(3012516) Albumin [Mass/volume] in Urine
4006
31488
1.39
60.70
3.4
3.3
mg/l
437.4
408.8
0.14
2618
19982
(3024263) Appearance of Synovial fluid
193
533
3.66
59.52
2.3
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
621
3108
2.05
58.61
1.2
1.3
titre
113.8
129.7
0.18
45
295
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
560
2702
2.12
58.28
1.3
1.3
u/ml
10.1
6.6
0.57
76
431
(3034770) Mitochondria Ab [Titer] in Serum
614
3074
2.05
57.89
1.2
1.3
titre
863.3
938.1
—
9
95
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1530
10039
1.59
57.63
2.5
2.3
g/l
0.2
0.2
1.09
1432
9366
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
550
2659
2.11
56.94
1.3
1.3
u/ml
4.6
4.6
0.01
48
271
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
4242
34004
1.36
55.79
2.8
2.6
u/l
56.3
58.1
0.68
3897
31447
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
2624
19399
1.44
55.59
1.6
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
586
2941
2.04
54.86
1.3
1.3
u/ml
34.2
38.6
0.11
23
176
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
470
2184
2.19
53.82
1.2
1.2
u/ml
13.4
17.9
—
6
27
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
2303
16749
1.45
52.94
3.1
2.9
e6/l
3.1
2.4
1.92
1289
8989
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
465
2192
2.16
51.35
1.3
1.2
u/ml
6.9
3.3
0.31
27
156
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
4009
32198
1.35
50.94
2.1
2.2
u/l
193.2
216.8
0.99
3749
30238
(3021960) Folate [Moles/volume] in Serum or Plasma
3036
23417
1.38
49.56
1.6
1.5
nmol/l
20.1
20.3
0.30
2639
20111
(3026008) Bacteria identified in Urine by Culture
3734
29792
1.35
49.15
3.2
3.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1450
9859
1.53
45.99
2.2
2.2
nmol/l
352.5
372.1
2.99
1331
9068
(3039162) Centromere protein B Ab [Units/volume] in Serum
313
1308
2.43
45.96
1.2
1.3
u/ml
77.3
59.1
0.41
16
93
(3017732) Neutrophils [#/volume] in Blood
1171
7598
1.59
45.69
3.5
2.8
e9/l
4.2
4.1
1.23
912
5974
(3002032) Base excess in Venous blood by calculation
1390
9441
1.53
44.21
4.3
4.1
mmol/l
2.0
1.9
0.24
1135
7694
(3052851) Hemolysis interference index of Serum or Plasma
588
3185
1.89
43.99
2.7
3.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
487
2475
2.00
43.98
4.5
4.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
5391
45837
1.30
43.83
3.2
2.8
ug/l
142.4
131.9
1.47
4985
42610
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
3561
28604
1.34
43.72
3.0
3.0
ng/l
1349.0
1275.2
0.44
3017
24420
(3023520) Reticulocytes [#/volume] in Blood
1266
8446
1.55
43.68
2.4
2.6
e9/l
71.6
70.6
0.35
928
6371
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2320
17438
1.40
43.39
3.4
3.5
mmol/l
0.8
0.8
9.71
2174
16324
(3019309) Folate [Moles/volume] in Red Blood Cells
2453
18638
1.39
42.97
1.8
1.7
nmol/l
1132.1
1168.3
1.20
1890
14171
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
443
2195
2.05
42.91
1.2
1.2
u/ml
38.6
43.9
0.23
31
223
(40761536) Microorganisms panel - Urine sediment
1329
8995
1.53
42.90
4.4
3.8
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1381
9462
1.51
42.04
4.4
4.1
kpa
5.8
5.8
0.11
1342
9182
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2204
16510
1.40
41.88
1.9
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
10765
100666
1.37
41.79
6.7
5.6
mmol/mol
40.6
39.6
15.81
10044
93648
(3020630) Protein [Mass/volume] in Serum or Plasma
1251
8427
1.54
41.20
2.0
2.6
g/l
67.1
66.6
1.67
1155
7696
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1652
11790
1.46
40.96
3.5
4.4
u/l
240.0
242.9
0.31
1559
11137
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
3575
28948
1.32
40.95
1.9
1.7
mmol/l
1.6
1.4
18.08
3048
24383
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1874
13735
1.42
40.18
6.1
6.2
mmol/l
1.0
1.0
0.04
1770
12864
(3019550) Sodium [Moles/volume] in Serum or Plasma
11806
112374
1.47
39.77
19.4
15.5
mmol/l
139.5
139.7
14.74
11549
109692
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
10661
99764
1.35
39.41
5.1
4.6
mu/l
1.9
2.1
3.53
9874
91800
(3004588) Protein electrophoresis panel - Serum or Plasma
1055
6917
1.57
39.14
1.9
2.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
2884
22768
1.34
39.04
5.0
3.9
kg/l
1.0
1.0
0.61
443
3383
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
9081
83151
1.29
38.90
4.2
3.9
pmol/l
14.7
14.7
0.03
8328
76054
(3004809) Band form neutrophils/100 leukocytes in Blood
363
1732
2.13
38.89
2.8
3.4
%
1.1
1.5
1.27
283
1347
(3023103) Potassium [Moles/volume] in Serum or Plasma
11829
112757
1.46
38.30
19.5
15.7
mmol/l
4.0
4.0
0.72
11562
109861
(3005322) IgE [Units/volume] in Serum or Plasma
1031
6786
1.56
37.56
1.3
1.3
u/ml
350.5
231.1
2.25
974
6277
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
182
648
2.83
37.01
1.6
1.5
u/ml
20.6
24.8
0.65
38
134
(3024354) Oxygen [Partial pressure] in Venous blood
1138
7707
1.52
36.36
3.7
3.4
kpa
4.7
4.7
0.30
1099
7453
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
8263
75047
1.27
36.23
3.8
3.1
u/l
59.7
48.2
16.77
7722
70347
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
558
3170
1.79
35.76
1.8
1.7
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
161
549
2.96
35.44
1.3
1.3
titre
74.7
59.8
0.31
15
44
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2981
23935
1.32
35.30
1.8
1.8
mg/l
1.2
1.2
0.01
2359
18237
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1552
11278
1.43
34.51
1.8
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
808
5127
1.61
34.33
4.0
3.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
549
3142
1.78
34.32
1.6
1.7
g/l
0.3
0.2
5.70
525
2971
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
738
4603
1.64
33.61
1.7
1.7
g/l
1.6
1.5
1.21
625
3929
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1903
14384
1.38
33.52
1.9
1.8
%
1.6
1.4
17.20
1622
12672
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
161
569
2.85
33.24
1.3
1.3
titre
892.5
486.9
0.42
12
39
(3030981) Hyaline casts [#/volume] in Urine by Automated count
847
5493
1.58
32.80
2.9
2.7
e6/l
0.3
0.3
0.09
825
5350
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1546
11337
1.41
32.53
1.9
1.7
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
556
3248
1.74
32.36
1.6
1.7
g/l
1.3
1.2
6.51
534
3082
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
4681
40134
1.26
32.34
3.9
3.4
ng/l
60.6
62.1
0.03
3164
26524
(3009445) Proteinase 3 Ab [Units/volume] in Serum
735
4631
1.62
32.12
1.4
1.6
u/ml
5.7
16.5
2.95
17
135
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1216
8591
1.46
31.32
3.8
3.8
mmol/l
1.2
1.2
0.12
1086
7540
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
2746
22132
1.30
31.00
1.8
1.7
pmol/l
51019019.9
31270999.8
0.52
2258
18535
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
653
4034
1.65
30.86
2.0
2.0
ug/l
2.3
2.0
0.32
584
3589
(3013166) Neutrophils/100 leukocytes in Synovial fluid
107
312
3.45
30.60
1.5
1.3
%
49.6
54.3
0.60
86
265
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
334
1695
2.00
30.34
1.3
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1669
12596
1.37
29.37
3.0
2.8
umol/l
8.5
8.4
0.02
1443
10947
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
626
3887
1.64
28.99
1.8
2.3
g/l
4.2
3.8
2.92
445
2801
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
626
3893
1.64
28.81
1.8
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
626
3896
1.64
28.72
1.8
2.3
g/l
7.6
7.3
2.05
460
2933
(3015377) Calcium [Moles/volume] in Serum or Plasma
4138
35335
1.25
28.69
3.1
3.5
mmol/l
2.4
2.4
0.33
3656
31028
(3045424) Erythrocytes [Presence] in Urine
341
1779
1.94
28.62
1.5
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
249
1161
2.17
28.39
2.8
2.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
283
1389
2.06
28.22
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
11903
114499
1.40
27.98
17.6
12.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
3339
27954
1.26
27.21
4.7
4.0
%
90.4
91.0
0.73
3244
27240
(3022145) Colonoscopy Study observation
1626
12388
1.36
26.77
1.5
1.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
714
4689
1.55
26.09
3.1
3.1
%
0.7
0.7
0.20
688
4497
(40768797) Stomach Pathology biopsy report
1917
15021
1.32
26.04
1.3
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
904
6244
1.48
26.01
3.8
3.5
g/l
129.2
130.0
0.52
889
6087
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1432
10741
1.37
25.99
3.7
3.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
1718
13269
1.34
25.77
7.7
7.4
mmol/l
104.2
104.5
1.94
1684
12985
(3027273) Bicarbonate [Moles/volume] in Venous blood
729
4847
1.53
25.18
3.9
3.6
mmol/l
25.5
25.2
1.02
719
4696
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
575
3632
1.61
24.84
1.8
2.3
g/l
10.5
10.2
0.52
492
3055
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
11003
104962
1.29
24.78
4.7
3.9
mmol/l
1.4
1.3
55.69
10243
96841
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
11401
109309
1.31
24.42
5.3
4.3
mmol/l
4.6
4.7
17.09
10736
101988
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
239
1171
2.06
24.01
1.2
1.2
u/l
58.4
65.9
0.87
171
778
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
528
3311
1.62
23.51
1.9
2.4
g/l
0.8
0.9
0.29
461
2858
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
574
3673
1.59
23.49
1.8
2.3
g/l
3.1
3.1
1.18
448
2871
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
11090
106062
1.28
23.34
4.9
4.4
mmol/l
6.1
5.9
33.66
10196
97450
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
281
1479
1.92
23.05
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
837
11782
0.69
22.97
1.3
1.4
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
83
249
3.35
22.81
1.5
1.2
%
49.2
37.3
1.81
62
163
(3025941) Bacteria identified in Stool by Culture
872
6166
1.44
22.15
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1342
10229
1.35
21.78
3.0
2.5
u/l
34.7
45.1
1.22
1171
8792
(3044889) 12 lead EKG panel
8244
76634
1.20
21.76
3.8
3.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
324
1820
1.80
21.66
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
12556
122536
1.49
21.61
30.9
20.0
e9/l
257.6
251.4
21.25
12371
119538
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
472
2943
1.63
21.52
1.9
2.3
g/l
0.0
0.0
0.66
439
2686
(3013512) EKG study
3541
30456
1.22
21.50
4.1
3.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
1184
8905
1.36
20.93
8.8
8.8
—
—
—
0
0
(3024731) MCV [Entitic volume]
12557
122622
1.48
20.73
30.8
19.9
fl
91.8
90.9
79.54
12457
121036
(36660697) Celiac disease serology panel - Serum
1127
8424
1.37
20.71
1.2
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
12557
122636
1.47
20.57
31.0
19.9
e12/l
4.5
4.5
16.04
12338
119318
(3010813) Leukocytes [#/volume] in Blood
12559
122660
1.47
20.56
31.0
20.0
e9/l
7.0
6.7
67.70
12342
119317
(3035941) MCH [Entitic mass]
12554
122607
1.47
20.50
30.8
19.9
pg
30.5
30.3
25.96
12453
121022
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
464
2921
1.61
20.36
1.5
1.5
iu/ml
7.1
14.3
1.96
14
63
(3014111) Lactate [Moles/volume] in Serum or Plasma
1222
9274
1.35
20.36
7.4
7.4
mmol/l
1.4
1.3
0.70
1167
8950
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
477
3025
1.60
20.30
1.9
2.2
g/l
37.5
38.0
0.82
418
2616
(3000963) Hemoglobin [Mass/volume] in Blood
12558
122674
1.47
20.26
31.1
20.1
g/l
136.1
136.5
3.26
12455
121090
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
632
4276
1.50
20.10
1.1
1.1
u/ml
26.1
11.5
0.37
13
65
(3035947) Staphylolysin Ab [Units/volume] in Serum
123
493
2.51
20.02
1.1
1.1
iu/ml
3.4
3.5
0.06
11
31
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
559
3689
1.54
19.99
2.2
2.4
ug/l
470.9
615.2
0.64
508
3456
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
558
3683
1.54
19.94
1.6
1.6
titre
514.5
272.3
0.68
22
155
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1042
7747
1.37
19.78
4.1
4.0
ng/l
86.8
91.7
0.95
881
6737
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
437
2737
1.62
19.59
1.9
2.3
g/l
0.0
0.0
0.09
406
2487
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
605
4082
1.51
19.50
1.6
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
693
4806
1.47
19.49
1.8
1.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
1136
8584
1.35
19.44
4.4
3.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
347
2053
1.71
19.39
1.7
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
430
2697
1.61
19.17
1.9
2.3
g/l
0.0
0.0
0.00
403
2480
(3024980) IgG subclass 4 [Mass/volume] in Serum
313
1809
1.75
19.03
1.5
1.6
g/l
0.6
0.8
3.36
237
1361
(3015235) Bicarbonate [Moles/volume] in Capillary blood
412
2569
1.62
18.82
3.6
3.0
mmol/l
25.2
24.7
1.43
365
2239
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
11508
111114
1.27
18.74
5.4
4.8
mmol/l
2.7
2.8
10.51
10739
103054
(3027801) Oxygen [Partial pressure] in Arterial blood
1527
12113
1.29
18.50
7.8
7.6
kpa
12.0
12.5
2.78
1456
11567
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
31
50
6.21
18.43
1.2
1.2
mg/l
1.6
1.7
0.27
24
41
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1527
12120
1.29
18.42
7.9
7.6
kpa
5.2
5.1
5.90
1461
11583
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
11271
108606
1.26
18.35
4.9
4.3
mmol/l
1.4
1.5
38.93
10512
100860
(3017354) Segmented neutrophils/100 leukocytes in Blood
207
1071
1.95
17.97
2.8
3.4
%
58.5
57.9
0.14
132
702
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
701
4957
1.44
17.79
4.6
4.5
mmol/l
24.1
24.1
0.00
622
4456
(3000570) Elastase.pancreatic [Mass/mass] in Stool
480
3147
1.55
17.71
1.4
1.4
ug/g
273.8
274.9
0.04
282
1811
(3003396) Base excess in Arterial blood by calculation
1518
12100
1.29
17.67
7.9
7.6
mmol/l
1.2
1.0
1.43
1238
9509
(3008757) Leukocyte morphology finding [Identifier] in Blood
214
1127
1.91
17.63
3.3
3.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1377
10843
1.30
17.60
8.2
8.0
%
95.2
95.7
2.48
1336
10434
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
149
694
2.16
17.23
1.5
1.6
u/l
9.5
5.3
1.29
79
328
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
347
2121
1.65
17.19
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
347
2121
1.65
17.19
1.4
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
359
2216
1.64
17.12
1.5
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
882
6559
1.37
16.68
4.1
3.4
kpa
5.2
5.1
0.88
816
6079
(3001729) Color of Synovial fluid
37
78
4.75
16.54
1.9
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
365
2284
1.62
16.48
4.5
6.0
iu/ml
596.4
2016.5
1.08
39
346
(3020779) Urea [Moles/volume] in Serum or Plasma
1208
9444
1.31
16.25
7.8
7.9
mmol/l
10.2
9.6
2.18
1165
9030
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1974
16397
1.24
16.09
2.0
2.2
s
30.1
29.8
1.41
1917
15930
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
189
986
1.93
16.07
1.3
1.3
titre
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
442
2915
1.53
15.91
1.3
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
691
4977
1.41
15.83
1.1
1.1
titre
193.3
223.2
0.12
15
125
(3027135) IgG subclass 1 [Mass/volume] in Serum
207
1123
1.86
15.62
1.2
1.4
g/l
6.6
6.8
0.32
147
775
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
800
5919
1.37
15.61
1.7
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
655
4692
1.42
15.48
1.8
1.9
u/l
38.8
39.3
0.26
586
4161
(3004616) Nuclear Ab [Presence] in Serum
231
1300
1.79
15.48
1.3
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2405
20463
1.21
15.47
3.9
3.7
ng/l
326.5
524.1
2.15
1761
15522
(3009343) pH of Capillary blood
863
6476
1.36
15.40
4.1
3.4
ph
7.4
7.4
0.49
125
817
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
469
3155
1.50
15.39
2.4
3.3
mg/l
49.9
46.9
0.08
363
2549
(3021901) Oxygen saturation in Capillary blood
303
1843
1.66
15.35
3.5
2.8
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
469
3158
1.50
15.32
2.4
3.3
mg/l
68.5
72.7
0.07
363
2548
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
7601
71168
1.16
15.07
3.0
2.9
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
457
3072
1.51
15.06
2.4
3.2
ratio
1.5
3.0
1.19
31
243
(3023183) Ammonium ion [Moles/volume] in Plasma
361
2304
1.58
15.05
3.7
2.8
umol/l
36.0
34.3
0.64
304
1974
(3028192) IgG subclass 2 [Mass/volume] in Serum
205
1123
1.84
15.02
1.2
1.4
g/l
3.3
3.0
1.69
144
778
(3024139) IgG subclass 3 [Mass/volume] in Serum
205
1123
1.84
15.02
1.2
1.4
g/l
0.4
0.4
0.01
144
777
(21494815) CD4 cells/100 lymphocytes in Specimen
177
926
1.92
14.96
2.1
2.3
%
44.5
41.2
0.52
24
128
(3037756) Immunofixation for Serum or Plasma
332
2091
1.60
14.65
1.3
1.7
—
—
—
0
0
(4062490)
203
1120
1.83
14.55
1.3
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
157
796
1.98
14.55
1.2
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
153
770
2.00
14.48
2.0
2.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
260
1545
1.70
14.42
1.1
1.1
g/l
1.6
1.5
3.16
243
1399
(1175426) CD3 cells/100 lymphocytes in Blood
161
829
1.95
14.28
1.9
2.0
%
73.2
72.9
0.09
156
790
(3020717) Zinc [Moles/volume] in Serum or Plasma
119
548
2.18
14.25
1.3
1.5
umol/l
18.2
25.0
2.23
113
523
(40759836) Histone Ab [Presence] in Serum by Immunoblot
156
796
1.97
14.21
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
156
797
1.97
14.16
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
157
804
1.96
14.15
1.2
1.1
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
827
6247
1.35
14.13
4.1
3.4
mmol/l
2.0
1.7
1.13
607
4628
(3028626) Oxygen [Partial pressure] in Capillary blood
352
2271
1.57
14.03
4.1
3.0
kpa
8.1
8.2
0.68
329
2103
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
156
803
1.95
13.86
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
156
803
1.95
13.86
1.2
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
801
6048
1.35
13.73
1.6
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
157
813
1.94
13.72
1.9
2.0
%
13.6
14.4
0.34
64
378
(3037121) Protein [Mass/volume] in Urine
511
3580
1.44
13.68
3.4
3.2
g/l
0.3
0.3
0.17
257
1567
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
504
3523
1.45
13.66
2.5
2.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
520
3657
1.44
13.64
1.7
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
252
1508
1.68
13.64
1.4
1.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
595
4296
1.40
13.47
5.1
5.4
%
1.7
1.7
0.31
563
4004
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
753
5650
1.35
13.45
9.6
9.7
mmol/l
24.5
24.3
1.31
686
5300
(3022217) INR in Platelet poor plasma by Coagulation assay
1621
13427
1.24
13.40
22.6
23.5
inr
1.2
1.3
1.32
240
1967
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
117
549
2.14
13.39
1.1
1.1
u/l
27.0
24.3
0.12
95
418
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2196
18756
1.20
13.37
2.9
3.1
mmol/l
2.5
2.4
2.76
1930
16433
(3035611) Eosinophils/100 leukocytes in Synovial fluid
30
64
4.70
13.26
2.1
1.3
%
0.5
0.7
0.28
19
47
(40768804) Tissue Pathology biopsy report
4856
44266
1.15
13.26
2.1
2.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
293
1837
1.61
13.22
1.1
1.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
117
552
2.13
13.21
1.1
1.1
u/l
81.8
86.8
0.20
95
436
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5528
50880
1.15
13.12
4.3
4.0
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
89
377
2.37
13.02
1.1
1.2
g/l
0.1
0.2
—
5
26
(3036670) Protein [Mass/volume] in Synovial fluid
78
312
2.51
12.92
1.3
1.2
g/l
39.7
39.2
0.11
52
169
(3044640) Blood type and Crossmatch panel - Blood
3807
34138
1.16
12.91
2.6
2.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
84
348
2.42
12.91
1.1
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
187
1048
1.80
12.80
2.3
2.5
e9/l
1.1
1.2
0.30
129
616
(3007930) Methemoglobin/Hemoglobin.total in Blood
582
4235
1.39
12.60
5.2
5.5
%
0.8
0.9
2.68
553
3956
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
333
2181
1.54
12.46
1.8
2.1
nmol/l
0.9
0.8
0.80
272
1842
(3009542) Hematocrit [Volume Fraction] of Blood
10515
101452
1.18
12.45
22.2
14.5
%
39.7
40.2
5.19
7397
75133
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
107
500
2.15
12.41
1.1
1.1
miu/ml
1326.9
1536.2
1.64
107
500
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
433
2997
1.46
12.39
1.9
2.0
mg/l
10.5
11.4
1.42
410
2782
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1239
10057
1.26
12.25
8.9
8.4
g/l
122.3
122.1
0.14
1205
9680
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
185
1048
1.78
12.23
1.3
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
229
1380
1.67
12.13
1.5
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
274
1728
1.60
12.10
1.3
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
93
418
2.23
11.90
1.9
2.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
80
338
2.38
11.81
1.9
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
278
1796
1.56
11.11
1.7
1.7
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
128
667
1.93
11.08
1.2
1.3
u/l
22.8
22.3
0.04
114
559
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
131
690
1.91
10.98
1.2
1.3
u/l
93.8
89.3
0.19
117
595
(42529406) Shigella sp [Presence] in Stool by Culture
438
3118
1.42
10.82
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
463
3330
1.40
10.79
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
436
3109
1.42
10.67
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
432
3081
1.42
10.57
1.2
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
125
657
1.91
10.57
1.2
1.5
u/l
5.4
6.1
0.87
110
557
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
232
1455
1.61
10.55
1.4
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
529
7081
0.74
10.53
1.5
1.4
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
147
818
1.81
10.40
1.3
1.2
u/ml
63.0
71.0
—
6
40
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
248
1586
1.57
10.39
1.5
1.4
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
124
655
1.90
10.34
2.5
2.7
e9/l
0.1
0.3
1.36
119
633
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
708
5474
1.31
10.32
2.5
2.4
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
142
784
1.82
10.31
1.3
1.2
u/ml
12.9
5.2
—
7
53
(40760888) Immunoglobulin light chains.free panel - Serum
351
2424
1.46
10.24
2.2
3.3
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
147
822
1.80
10.24
1.3
1.2
u/ml
92.4
39.5
—
9
61
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
270
1769
1.54
10.17
1.1
1.1
iu/ml
2178.8
5758.3
0.27
58
408
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
153
868
1.77
10.15
1.1
1.1
mg/l
298.9
285.8
0.97
138
781
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
159
913
1.75
10.12
1.3
1.2
titre
116.5
202.6
1.27
37
163
(1616796) Gas panel - Central venous blood
343
2366
1.46
10.07
4.1
3.6
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
149
841
1.78
10.06
1.3
1.2
u/ml
57.7
47.1
—
5
44
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
169
990
1.72
10.03
1.3
1.3
nmol/l
1.7
1.4
1.63
153
887
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
957
7717
1.26
10.01
2.3
2.4
au/ml
20.9
25.1
0.40
33
468
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
187
1131
1.66
9.86
1.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
279
1857
1.51
9.79
1.5
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
119
633
1.89
9.74
1.4
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
98
489
2.01
9.67
3.2
3.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
324
2231
1.46
9.62
3.2
2.4
%
16.4
16.5
0.32
188
1121
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
867
10745
0.79
9.61
1.7
1.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
358
2516
1.43
9.54
1.7
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
348
2436
1.44
9.48
1.7
1.7
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
166
987
1.69
9.36
1.2
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
285
4128
0.68
9.11
1.7
1.7
mg/l
3.8
3.6
0.20
223
2893
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
290
1979
1.48
9.04
2.9
3.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
107
565
1.90
8.99
1.5
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
139
796
1.75
8.99
1.5
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
106
560
1.90
8.90
1.5
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
136
777
1.76
8.87
1.6
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
872
7056
1.25
8.86
1.3
1.3
au/ml
52.3
49.8
0.07
21
308
(3014007) Fractional oxyhemoglobin in Arterial blood
837
6759
1.25
8.66
10.1
9.5
%
93.6
94.0
1.23
832
6736
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
217
1408
1.55
8.62
1.5
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
255
1714
1.50
8.60
1.5
1.4
mmol/l
62.1
63.7
0.22
190
1359
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
444
3304
1.36
8.48
2.2
2.2
u/l
3590.8
5071.4
0.63
151
1270
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
833
6740
1.25
8.48
10.0
9.4
%
1.4
1.4
0.18
826
6693
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
99
522
1.90
8.39
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
332
2361
1.42
8.35
2.6
2.1
g/l
129.8
130.5
0.21
242
1665
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
260
1770
1.48
8.25
2.3
2.8
u/ml
655.3
2000.0
1.02
16
97
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
874
7156
1.24
8.00
1.2
1.2
iu/ml
114.6
147.0
1.85
308
2734
(3042631) Mycobacterium sp identified in Specimen
214
1410
1.53
7.97
2.5
2.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
360
2622
1.38
7.90
2.3
2.4
ug/min
150.4
116.2
0.57
209
1601
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
98
527
1.87
7.85
1.2
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
305
2164
1.42
7.80
1.4
1.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
825
6733
1.24
7.79
10.2
9.4
%
0.7
0.7
0.60
819
6685
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
153
938
1.64
7.76
1.1
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
28
86
3.26
7.63
1.2
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
600
4731
1.28
7.61
4.3
3.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
675
5404
1.26
7.55
1.4
1.4
—
—
—
0
0
(4010399)
944
7848
1.22
7.47
1.5
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
396
2956
1.35
7.46
3.5
3.3
mg/l
1.6
1.5
0.61
357
2722
(3017569) Oxygen content in Arterial blood
88
466
1.89
7.42
1.7
2.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
56
252
2.23
7.31
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
56
252
2.23
7.31
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
56
252
2.23
7.31
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
56
252
2.23
7.31
1.1
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
1203
10268
1.19
7.18
1.9
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
178
1159
1.54
7.05
1.6
1.6
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
416
3157
1.33
7.04
2.5
2.7
g/l
3.8
3.6
1.69
393
3002
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
1318
11359
1.18
7.02
2.0
2.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
308
2234
1.39
6.98
3.4
3.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
834
6914
1.22
6.81
5.5
5.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
423
3241
1.32
6.71
1.3
1.3
miu/ml
214.1
220.8
0.11
148
1454
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
121
728
1.67
6.67
1.1
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
811
6736
1.22
6.51
3.1
3.3
pmol/l
4.5
4.5
0.16
719
6003
(3006922) Hepatitis E virus Ab [Presence] in Serum
128
787
1.63
6.50
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
127
780
1.63
6.48
2.6
2.8
e6/l
629.5
700.0
0.46
44
327
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
121
735
1.65
6.45
1.1
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
792
6577
1.22
6.37
8.4
7.4
mmol/l
25.2
24.6
4.65
740
6120
(3011288) Drugs identified in Urine by Screen method
360
2726
1.33
6.24
2.8
3.2
—
—
—
0
0
(3000492) Spirometry study
1263
10955
1.17
6.22
1.5
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
119
728
1.64
6.18
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
309
2290
1.36
6.18
1.7
1.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
212
1473
1.45
6.18
6.8
6.7
mg/l
11.8
11.4
0.56
201
1347
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
37
150
2.47
6.16
1.1
1.5
nmol/l
11.5
293030.0
1.08
24
129
(3035320) C reactive protein [Mass/volume] in Body fluid
124
769
1.62
6.11
2.7
2.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
310
2305
1.35
6.08
1.4
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
135
856
1.58
6.07
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
369
2816
1.32
6.06
1.2
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
151
983
1.54
6.05
3.3
3.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
395
3044
1.31
6.05
1.3
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
119
733
1.63
6.03
1.1
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
148
962
1.54
5.98
2.1
2.6
—
0.2
—
0
5
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
129
813
1.59
5.96
1.2
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
712
5897
1.22
5.90
10.2
10.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
823
6913
1.20
5.90
3.3
2.8
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
151
990
1.53
5.88
2.9
3.0
mg/l
52.5
51.4
0.02
108
720
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
31
118
2.63
5.87
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
304
2270
1.35
5.82
1.2
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
486
3870
1.27
5.78
2.6
2.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
87
499
1.75
5.77
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
479
5953
0.80
5.52
1.6
1.7
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
304
2292
1.33
5.48
1.4
1.4
u/ml
19.3
19.6
—
6
45
(3012494) Peanut IgE Ab [Units/volume] in Serum
55
277
1.99
5.47
1.0
1.1
u/ml
0.9
2.0
0.46
23
153
(3041672) Baker's yeast Ab [Presence] in Serum
18
52
3.46
5.44
1.1
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
120
762
1.58
5.41
2.4
2.6
e6/l
428.9
516.8
1.28
98
635
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
27
100
2.70
5.41
3.0
2.5
—
—
—
0
0
(3000012) Reticulocyte production index
92
548
1.68
5.36
1.5
1.4
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
30
118
2.55
5.35
1.2
1.1
u/ml
0.1
0.3
0.42
19
82
(3051611) Lipemic interference index of Serum or Plasma
163
1110
1.47
5.33
3.2
3.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
58
301
1.93
5.31
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
298
2255
1.33
5.26
4.0
3.4
mg/l
23.4
26.8
0.88
183
1402
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
175
1213
1.45
5.24
1.2
1.3
nmol/l
19.8
33.3
—
6
11
(3028707) Methadone [Presence] in Urine by Screen method
243
1785
1.37
5.21
2.8
2.9
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
279
2095
1.34
5.19
1.5
1.5
u/ml
105.8
114.3
0.86
67
449
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
32
132
2.43
5.19
4.6
9.9
umol/l
0.5
0.3
0.69
23
124
(3012501) Base excess in Blood by calculation
321
2463
1.31
5.14
4.4
3.9
mmol/l
2.5
2.5
0.03
235
1674
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
218
1578
1.39
5.12
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
283
2138
1.33
5.06
1.2
1.3
u/ml
294.7
272.5
0.61
186
1368
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
19
60
3.17
5.03
1.1
1.1
u/ml
37.8
23.8
—
5
22
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
19
60
3.17
5.03
1.1
1.1
u/ml
25.7
23.8
—
6
15
(3042111) Morphology [Interpretation] in Bone marrow Narrative
234
1723
1.36
4.97
1.6
1.6
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
23
82
2.81
4.96
1.6
1.6
mg/l
0.8
2.0
1.17
13
52
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
67
374
1.80
4.93
1.2
1.3
g/l
0.3
0.3
0.28
57
299
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
213
1551
1.38
4.86
3.0
2.8
u/ml
77.4
1039.8
0.89
208
1491
(3002619) Bacteria identified in Specimen by Culture
45
221
2.04
4.84
1.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
486
3955
1.24
4.84
1.9
1.8
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
114
736
1.55
4.84
2.5
2.7
e9/l
0.2
0.2
1.67
101
633
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
94
580
1.63
4.82
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
248
1852
1.35
4.82
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
146
995
1.47
4.80
1.3
1.2
—
—
—
0
0
(3010421) pH of Blood
362
2850
1.28
4.79
4.2
3.9
ph
7.4
7.4
0.13
317
2409
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
47
237
1.99
4.72
1.2
1.1
—
—
—
0
0
(3036603) Volume of Urine
113
735
1.54
4.65
1.6
1.7
ml
2047.4
2067.0
0.03
30
172
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
91
564
1.62
4.61
1.1
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
97
612
1.59
4.57
1.5
1.5
nmol/l
1.5
1.2
1.08
74
476
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
981
8561
1.16
4.51
3.0
2.9
ng/l
207.0
183.4
0.79
882
7749
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
70
408
1.72
4.48
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
524
4335
1.22
4.48
2.2
2.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
167
2324
0.71
4.47
1.6
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
154
1079
1.43
4.42
1.7
2.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
832
7182
1.17
4.41
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
428
3480
1.24
4.34
2.9
3.4
u/ml
0.3
0.3
0.40
256
1979
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
79
481
1.65
4.32
1.6
2.0
umol/l
139.0
127.7
0.08
40
240
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
239
1808
1.33
4.31
1.2
1.2
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
10
22
4.55
4.30
1.0
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
43
218
1.98
4.28
1.2
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
357
2849
1.26
4.27
1.1
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
121
816
1.49
4.25
1.4
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1019
8960
1.15
4.23
2.4
2.3
ug/l
6.0
8.0
4.22
888
7906
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
110
729
1.51
4.20
1.4
1.5
u/l
14.3
12.4
1.63
103
704
(3045716) Anion gap in Serum or Plasma
77
470
1.64
4.18
3.1
2.5
mmol/l
9.0
9.1
0.14
61
342
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
21
79
2.66
4.14
1.6
1.6
mg/l
3.5
4.4
0.25
11
50
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
21
79
2.66
4.14
1.6
1.6
mg/l
3.2
2.9
0.05
14
55
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
21
79
2.66
4.14
1.6
1.6
mg/l
1.6
2.3
0.36
13
56
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
21
79
2.66
4.14
1.6
1.6
mg/l
2.1
0.8
0.52
12
51
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
21
79
2.66
4.14
1.6
1.6
mg/l
1.9
2.6
0.24
12
51
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
21
79
2.66
4.14
1.6
1.6
mg/l
1.1
1.7
—
9
48
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
21
79
2.66
4.14
1.6
1.6
mg/l
2.1
2.2
0.03
12
58
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
21
79
2.66
4.14
1.6
1.6
mg/l
2.9
2.2
0.21
16
50
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
21
79
2.66
4.14
1.6
1.6
mg/l
0.4
1.0
1.47
14
53
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
133
919
1.45
4.14
1.7
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
133
919
1.45
4.14
1.7
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
133
919
1.45
4.14
1.7
1.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
370
2981
1.25
4.10
1.1
1.1
u/ml
2.4
7.1
3.43
32
400
(3047007) Chlamydophila sp Ab [Presence] in Serum
208
1555
1.34
4.08
1.2
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
98
638
1.54
4.08
3.0
2.8
%
38.2
38.9
0.10
36
228
(3013293) Extractable nuclear Ab [Presence] in Serum
34
161
2.11
4.07
1.7
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
101
662
1.53
4.07
3.5
3.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
395
3208
1.24
4.07
2.3
2.2
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
84
528
1.59
4.06
2.4
2.1
ug/min
116.0
167.2
0.33
23
119
(3032743) Legionella sp IgG Ab [Presence] in Serum
19
69
2.76
4.01
1.0
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
125
860
1.46
3.99
2.2
2.3
ml
683.1
665.7
0.14
78
603
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1022
9026
1.14
3.99
3.1
2.6
ml/min/173m2
65.5
67.6
0.92
428
3491
(40768800) Prostate Pathology biopsy report
167
2278
0.73
3.99
1.2
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
66
392
1.69
3.99
1.2
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
186
1377
1.36
3.91
1.4
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
178
1309
1.36
3.90
2.3
2.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
303
2402
1.27
3.88
1.5
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
63
374
1.69
3.83
1.3
1.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
92
600
1.54
3.82
2.3
2.6
u/ml
1007.6
1135.0
0.26
92
595
(21494567) Legionella sp IgM Ab [Presence] in Serum
19
71
2.68
3.81
1.0
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
101
673
1.50
3.80
14.4
12.3
mmol/l
0.6
0.6
0.03
93
615
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
325
2609
1.25
3.75
1.6
1.8
iu/l
3.0
7.8
0.86
106
966
(3040151) Glucose [Moles/volume] in Capillary blood
156
1135
1.38
3.68
6.7
12.7
mmol/l
7.9
7.4
0.82
140
944
(44813793)
110
758
1.45
3.54
1.1
1.1
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
6
6
10.00
3.49
1.2
1.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
134
960
1.40
3.49
2.0
1.4
promille
1.5
1.4
0.26
108
734
(3018405) Lactate [Moles/volume] in Arterial blood
441
3685
1.20
3.49
5.1
4.2
mmol/l
1.3
1.4
0.44
433
3619
(3036489) Thrombin time
483
4070
1.19
3.49
2.0
2.1
s
21.8
21.4
0.49
427
3525
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
55
324
1.70
3.47
1.1
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
107
737
1.46
3.46
1.1
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
43
236
1.82
3.45
2.0
2.5
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
67
417
1.61
3.44
1.8
2.2
%
11.4
10.2
0.38
62
386
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
115
804
1.43
3.44
1.8
2.0
u/field
3.3
1.7
1.08
48
347
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
413
3435
1.21
3.43
2.2
2.3
%
89.4
92.2
1.54
392
3186
(40761539) Cells [Type] in Urine sediment by Light microscopy
47
266
1.77
3.42
1.2
1.3
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
62
379
1.64
3.42
2.2
2.2
e6/l
382.7
2895.0
0.65
42
260
(3009466) Valproate [Moles/volume] in Serum or Plasma
209
1612
1.30
3.37
4.9
5.3
umol/l
350.1
369.4
1.09
172
1396
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
189
1438
1.32
3.37
1.6
1.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
200
1534
1.31
3.36
1.6
1.4
mu/l
69.7
62.3
0.21
178
1362
(3044242) Glucose [Moles/volume] in Arterial blood
76
491
1.55
3.34
1.8
2.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
203
1562
1.30
3.34
1.2
1.3
nmol/l
4.7
2.4
0.23
195
1510
(3008295) Osmolality of Serum or Plasma
143
1045
1.37
3.33
1.4
1.4
mosm/kgh2o
278.1
279.6
0.26
104
818
(3016038) Potassium [Moles/volume] in Urine
96
653
1.47
3.32
1.3
1.2
mmol/l
33.9
34.9
0.18
79
565
(3023511) Choriogonadotropin [Units/volume] in Urine
208
1609
1.30
3.29
1.4
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
273
2186
1.25
3.27
1.9
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
488
4142
1.19
3.27
4.5
3.7
mmol/l
24.6
24.9
1.63
455
3825
(3044007) Cell count panel - Peritoneal fluid
52
308
1.69
3.24
1.9
2.0
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
30
149
2.02
3.24
1.3
1.2
u/ml
29.0
2.4
—
5
38
(3004451) EKG impression Narrative
76
496
1.54
3.21
1.3
1.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
50
294
1.70
3.21
1.8
1.9
u/l
16.0
37.4
1.58
45
272
(3050129) First trimester maternal screen panel - Serum or Plasma
189
2446
0.77
3.21
1.6
1.4
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
26
123
2.12
3.18
1.2
1.2
mmol/l
6.0
6.2
0.02
12
62
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
77
505
1.53
3.18
1.5
1.6
nmol/l
3.4
9.0
0.58
65
415
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
106
742
1.43
3.18
1.2
1.3
u/ml
0.3
1.5
2.68
40
347
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
32
164
1.95
3.17
1.9
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
184
1409
1.31
3.16
1.6
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
299
2431
1.24
3.14
2.1
2.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2771
26087
1.08
3.11
2.6
2.3
—
—
—
0
0
(3020891) Body temperature
489
4173
1.18
3.09
6.0
5.0
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
40
223
1.80
3.09
1.3
1.5
g/l
22.4
25.2
0.49
26
168
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
374
3118
1.21
3.08
2.4
2.6
%
195.8
189.7
0.71
356
2967
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
183
1409
1.30
3.03
1.3
1.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
44
254
1.73
3.03
1.1
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
113
812
1.40
2.95
2.3
1.9
mmol/l
7.3
6.7
1.45
81
577
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
135
999
1.35
2.95
1.3
1.6
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
20
88
2.27
2.93
1.2
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
35
191
1.83
2.91
1.3
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
171
1313
1.31
2.91
2.0
1.9
titre
9308.6
1446.2
0.90
14
65
(3001964) Herpes simplex virus Ag [Presence] in Specimen
53
326
1.63
2.91
1.2
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
67
436
1.54
2.90
1.0
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
39
221
1.77
2.88
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
155
1176
1.32
2.88
1.1
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
100
708
1.42
2.86
1.2
1.3
u/l
14.6
12.9
0.43
87
656
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
54
336
1.61
2.84
2.2
2.0
e6/l
3611.0
15018.4
1.07
27
185
(3020650) Glucose [Presence] in Urine
48
290
1.66
2.83
1.4
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
401
3395
1.19
2.82
6.1
6.3
mmol/l
1.3
1.3
0.71
356
2994
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
123
908
1.36
2.75
1.2
1.3
mmol/l
13.8
11.6
1.80
52
249
(3024522) Salmonella sp identified in Specimen by Organism specific culture
181
1412
1.29
2.75
1.6
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
199
1572
1.27
2.74
1.3
1.3
nmol/l
0.1
0.2
1.79
11
111
(3033799) Differential panel - Peritoneal fluid
53
332
1.60
2.72
2.1
2.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
74
500
1.48
2.72
3.4
3.7
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
93
657
1.42
2.71
1.1
1.1
iu/ml
10.0
9.6
0.05
18
162
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
82
567
1.45
2.68
1.6
1.7
u/field
1.7
2.8
1.34
62
405
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
45
722
0.62
2.64
1.0
1.0
ng/l
337.4
329.5
0.05
30
519
(3016750) Collection duration of Urine
88
619
1.42
2.63
1.9
2.2
min
502.6
499.1
0.11
60
477
(3017315) Amylase [Enzymatic activity/volume] in Urine
85
595
1.43
2.62
1.2
1.2
u/l
278.4
399.9
0.62
79
549
(3017704) Immunofixation for Urine
77
529
1.46
2.61
1.2
1.6
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
308
2566
1.21
2.61
1.9
1.9
pmol/l
195.6
200.4
0.38
288
2435
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
139
1055
1.32
2.61
1.8
1.8
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
33
184
1.80
2.59
1.1
1.0
—
0.6
—
0
5
(3016879) Cocaine [Presence] in Urine
450
3878
1.17
2.58
2.3
2.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
58
377
1.54
2.57
1.1
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
178
1400
1.28
2.57
1.6
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
141
1076
1.31
2.55
1.3
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
154
1190
1.30
2.55
1.2
1.4
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
20
94
2.13
2.54
1.0
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
82
574
1.43
2.53
1.3
1.5
ug/l
7.5
7.9
0.12
72
518
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
46
726
0.63
2.53
1.0
1.0
ng/l
39.6
42.7
0.17
31
508
(3022493) Free Hemoglobin [Mass/volume] in Plasma
67
452
1.48
2.50
1.5
5.8
mg/l
70.1
1500.5
1.09
41
328
(3005988) Vibrio sp identified in Specimen by Organism specific culture
178
1405
1.27
2.50
1.6
1.5
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
46
723
0.63
2.49
1.0
1.0
ng/l
830.9
730.5
0.60
29
502
(3019977) pH of Arterial blood
81
568
1.43
2.49
3.1
2.8
ph
7.4
7.4
0.85
34
188
(3020876) Protein [Mass/time] in 24 hour Urine
122
916
1.33
2.48
1.8
1.9
g/24h
2.4
1.1
—
9
57
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
166
2104
0.79
2.47
1.5
1.5
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
11
39
2.82
2.47
1.4
1.2
u/field
1.0
1.2
—
6
24
(3025018) Bordetella pertussis Ab [Titer] in Serum
84
594
1.42
2.47
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
316
3745
0.84
2.45
1.6
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
413
3552
1.17
2.45
1.7
1.7
mu/l
265.4
294.0
1.80
373
3217
(3046861) Legionella sp Ag [Presence] in Urine
12
45
2.67
2.44
1.0
1.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
119
893
1.34
2.44
1.2
1.1
nmol/l
360.3
363.6
0.06
89
769
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
180
1429
1.26
2.42
1.4
1.3
pmol/l
284.9
303.6
0.24
136
1079
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
177
1404
1.26
2.40
1.6
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
121
1589
0.76
2.39
1.5
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
476
4148
1.15
2.38
2.2
2.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
28
153
1.83
2.37
1.4
1.6
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
14
58
2.42
2.36
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
154
1956
0.78
2.35
1.5
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
480
4190
1.15
2.35
2.2
2.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
984
8970
1.10
2.34
1.6
1.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
24
125
1.92
2.34
1.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
154
1954
0.79
2.34
1.5
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
205
1660
1.24
2.34
1.1
1.1
au/ml
11.9
11.8
0.01
11
96
(3005033) Fetal Nuchal fold Thickness US
121
1583
0.76
2.33
1.5
1.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
114
857
1.33
2.33
1.2
1.3
mmol/l
2.1
2.1
0.06
105
805
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
60
403
1.49
2.32
1.2
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
154
1950
0.79
2.30
1.5
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
63
428
1.47
2.30
2.4
2.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
101
1351
0.75
2.29
1.5
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
478
4181
1.15
2.28
2.2
2.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
154
1947
0.79
2.28
1.5
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
147
1149
1.28
2.27
1.8
1.7
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
88
638
1.38
2.27
1.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
6
13
4.62
2.27
3.7
2.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
127
1642
0.77
2.25
1.5
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
187
2308
0.81
2.24
1.3
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
34
201
1.69
2.23
2.7
2.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
470
4115
1.15
2.22
2.2
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
538
4754
1.14
2.22
1.8
1.8
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
18
86
2.09
2.22
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
66
457
1.45
2.21
3.4
2.9
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
208
1702
1.23
2.18
2.8
3.0
nmol/l
0.9
0.8
0.68
161
1267
(40761995) Spermatozoa Progressive [#/volume] in Semen
13
282
0.46
2.16
1.8
3.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
24
129
1.86
2.16
1.0
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
320
2730
1.18
2.14
1.2
1.3
mg/l
476.4
520.0
1.34
299
2602
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
13
281
0.46
2.14
3.7
6.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
47
306
1.54
2.12
1.1
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
55
802
0.68
2.12
1.0
1.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
118
906
1.31
2.11
1.3
1.3
u/l
584.8
378.6
0.44
109
861
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
190
1547
1.23
2.10
1.1
1.1
u/ml
2.4
3.5
1.12
68
755
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
68
479
1.42
2.09
1.5
2.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
78
563
1.39
2.09
2.0
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
78
563
1.39
2.09
2.0
2.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
78
563
1.39
2.09
2.0
2.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
161
1288
1.25
2.08
2.2
2.0
mg/l
36.5
25.5
1.07
51
337
(3019225) pH of Specimen
1121
10349
1.09
2.07
4.2
4.2
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
6
15
4.00
2.04
1.0
1.0
—
—
—
0
0
(44790047)
150
1195
1.26
2.02
1.7
1.5
—
—
—
0
0
(44790048)
150
1195
1.26
2.02
1.7
1.5
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
12
50
2.40
2.02
1.1
1.0
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
42
270
1.56
2.02
1.3
1.3
ug/l
194.1
246.2
0.09
25
147
(3010937) Rubella virus Ab [Presence] in Serum
14
63
2.22
2.00
1.1
1.1
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
45
296
1.52
1.96
1.7
2.1
e6/l
258.6
472.1
0.37
28
150
(3032057) Clostridioides difficile [Presence] in Stool
36
225
1.60
1.95
1.8
1.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
365
3177
1.15
1.92
5.7
4.4
mmol/l
3.9
3.9
0.84
343
2992
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
77
564
1.37
1.92
2.0
2.1
—
—
—
0
0
(44806118)
149
1195
1.25
1.92
1.7
1.5
—
—
—
0
0
(44790049)
149
1195
1.25
1.92
1.7
1.5
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
16
78
2.05
1.90
1.1
1.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
20
106
1.89
1.90
1.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
1520
14262
1.07
1.89
1.3
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
97
738
1.32
1.89
1.2
1.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
56
390
1.44
1.87
2.1
2.1
ug/l
58.6
63.6
0.17
56
380
(4146454)
140
1120
1.25
1.85
2.9
2.7
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
280
2397
1.17
1.85
1.2
1.3
mmol/l
3.8
3.8
0.16
257
2259
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
1307
12208
1.08
1.84
1.7
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
665
6029
1.11
1.83
2.0
1.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
145
1167
1.25
1.83
1.7
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
146
1178
1.24
1.80
1.4
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
43
287
1.50
1.78
1.4
2.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
279
2398
1.17
1.77
1.3
1.4
e6/l
660.8
2995.0
0.86
216
1940
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
110
861
1.28
1.76
2.1
2.0
nmol/l
16.4
18.3
1.49
105
810
(44806420)
40
265
1.51
1.72
2.4
2.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
75
559
1.34
1.71
1.3
1.6
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
20
111
1.80
1.68
2.3
2.4
u/field
0.7
0.6
0.22
20
111
(3027540) Rickettsia typhi Ab [Titer] in Serum
6
19
3.16
1.66
1.0
1.1
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
8
31
2.58
1.65
1.3
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
162
1336
1.22
1.65
1.1
1.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
13
62
2.10
1.65
1.0
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
117
932
1.26
1.64
1.4
1.3
mmol/l
6.2
6.4
0.30
109
858
(3034092) Cytoplasmic Ig cells/100 cells in Blood
24
142
1.69
1.64
24.3
7.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
49
343
1.43
1.63
3.3
3.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
277
2399
1.16
1.62
1.2
1.4
e6/l
18.3
32.8
0.93
205
1833
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
46
319
1.44
1.61
1.1
1.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
10
43
2.33
1.60
1.0
1.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
89
688
1.30
1.60
1.7
1.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
46
321
1.43
1.56
1.0
1.2
%
108.5
104.3
0.28
41
294
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
87
673
1.29
1.56
1.7
1.4
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
71
534
1.33
1.55
1.6
1.6
mmol/24h
3.9
6.0
—
5
43
(3003434) Protein [Mass/volume] in Pleural fluid
161
1338
1.21
1.54
1.5
1.5
g/l
33.5
33.1
0.15
146
1209
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
33
216
1.53
1.53
1.8
1.6
ng/l
137.6
130.1
0.10
33
216
(1002224) Polysomnography panel
551
5002
1.11
1.53
1.0
1.1
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
5
15
3.33
1.52
1.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
5
15
3.33
1.52
2.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
5
15
3.33
1.52
1.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
5
15
3.33
1.52
1.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
5
15
3.33
1.52
2.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
5
15
3.33
1.52
2.0
2.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
20
115
1.74
1.52
1.2
1.3
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
17
93
1.83
1.51
2.6
1.9
%
67.1
59.4
—
8
60
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
25
154
1.62
1.49
1.1
1.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
55
401
1.37
1.48
1.5
2.0
u/ml
866.2
16681.9
—
6
55
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
48
342
1.40
1.47
1.2
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
56
410
1.37
1.47
1.1
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
127
1037
1.23
1.47
1.9
1.9
—
1.1
—
0
5
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
44
309
1.43
1.46
1.0
1.2
%
96.1
87.4
0.58
22
155
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
22
132
1.67
1.45
1.1
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
605
5535
1.10
1.45
1.1
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
38
260
1.46
1.45
1.2
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
70
533
1.31
1.43
1.1
1.1
u/ml
1.2
17.4
—
6
47
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
64
481
1.33
1.43
1.1
1.3
umol/l
4.1
4.5
0.44
58
448
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
425
3824
1.12
1.42
3.4
3.6
u/ml
604.5
1750.8
0.82
362
3290
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2835
29390
0.95
1.41
3.9
4.1
%
22.3
21.7
1.10
1203
13765
(4133840)
47
337
1.40
1.40
1.2
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
130
1070
1.22
1.40
1.5
1.5
e6/l
31179.5
57517.2
1.35
75
635
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
91
721
1.26
1.39
1.5
1.4
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
35
238
1.47
1.38
1.2
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
34
230
1.48
1.38
1.1
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
99
793
1.25
1.38
1.6
1.5
umol/l
73.8
71.8
—
5
60
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
33
222
1.49
1.37
1.3
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
153
1285
1.19
1.35
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
257
2250
1.15
1.35
1.2
1.4
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
12
61
1.97
1.32
1.3
1.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
141
1179
1.20
1.31
1.5
1.5
e6/l
4664.5
2293.1
1.10
98
853
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
203
1751
1.16
1.31
1.3
1.2
u/ml
3.3
3.1
0.10
72
580
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
29
192
1.51
1.31
2.0
2.8
mg/l
45.2
48.6
—
7
34
(3022689) Creatine [Moles/volume] in Urine
45
325
1.39
1.31
1.3
1.5
—
—
—
0
0
(3035082) Kappa light chains [Mass/volume] in Urine
6
24
2.50
1.30
1.0
1.0
g/l
—
0.0
—
0
8
(3026692) Albumin [Mass/volume] in Peritoneal fluid
39
275
1.42
1.30
2.0
1.6
g/l
12.3
13.0
0.16
28
209
(3012565) Volume of 24 hour Urine
72
560
1.29
1.29
1.8
2.2
ml
2009.0
1989.1
0.06
66
502
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
15
84
1.79
1.26
1.2
1.2
%
49.6
16.0
—
5
23
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
44
320
1.38
1.24
1.0
1.1
%
93.5
87.3
0.51
21
157
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
61
467
1.31
1.24
3.0
2.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
227
1985
1.15
1.23
1.5
1.7
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
13
70
1.86
1.23
1.0
1.0
u/ml
0.1
0.2
—
6
29
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
63
485
1.30
1.23
2.2
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
63
485
1.30
1.23
2.2
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
199
1725
1.16
1.22
1.2
1.2
u/l
34.8
33.2
0.07
180
1495
(3042517) Benzodiazepines panel - Urine
20
124
1.61
1.20
1.9
2.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
67
853
0.78
1.20
1.2
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
47
348
1.35
1.20
2.9
2.3
ug/l
1.3
0.9
0.33
40
323
(4211845)
71
558
1.27
1.19
5.0
3.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
185
1599
1.16
1.19
2.5
2.1
titre
12.2
6.9
0.22
13
41
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
13
71
1.83
1.19
1.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
68
532
1.28
1.19
1.7
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
68
532
1.28
1.19
1.7
1.4
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
11
57
1.93
1.16
1.0
1.0
u/ml
4.9
0.3
—
6
39
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
11
57
1.93
1.16
1.3
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
126
0.48
1.16
1.7
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
18
110
1.64
1.15
1.1
1.1
—
—
—
0
0
(4034850)
321
3566
0.90
1.15
12.7
9.4
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
25
166
1.51
1.14
4.2
6.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
65
510
1.28
1.12
5.3
3.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
2042
21207
0.96
1.11
2.8
2.9
ug/l
0.6
0.7
5.11
1340
13692
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1384
13196
1.05
1.11
8.0
6.7
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
78
627
1.25
1.11
1.1
1.1
u/ml
9.7
1.9
0.39
23
172
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
13
73
1.78
1.10
2.7
1.8
%
10.8
18.3
—
5
40
(3015183) Erythrocyte sedimentation rate
73
583
1.25
1.10
1.2
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
109
909
1.20
1.09
1.6
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
131
1111
1.18
1.09
2.2
2.0
umol/l
6.8
8.5
0.56
106
801
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
195
1706
1.15
1.09
1.3
1.2
u/ml
4.6
3.8
0.44
84
754
(3003338) MCHC [Mass/volume]
9563
94682
1.04
1.08
27.0
17.3
g/l
332.0
332.8
15.11
9515
94024
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
56
434
1.29
1.07
2.3
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
56
434
1.29
1.07
2.3
2.3
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
74
594
1.25
1.07
2.2
2.4
umol/l
60.1
30.2
—
7
59
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
14
230
0.61
1.06
1.1
1.1
u/ml
59.0
60.4
0.03
14
221
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
103
859
1.20
1.04
1.8
1.9
mg/l
3.2
4.0
2.92
94
823
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
51
392
1.30
1.04
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
183
1600
1.15
1.04
1.3
1.4
u/l
25.3
28.8
0.88
150
1316
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
99
823
1.20
1.04
1.1
1.1
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
7
34
2.06
1.02
1.0
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
82
998
0.82
1.02
1.2
1.3
pmol/l
60.5
96.2
0.59
42
318
(3012441) Differential panel - Pleural fluid
121
1028
1.18
1.01
1.5
1.5
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
948
8972
1.06
1.01
2.3
2.2
nmol/l
12.6
12.9
0.57
819
8012
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
56
439
1.28
1.00
2.3
2.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
68
547
1.24
0.99
1.2
1.3
%
64.7
66.4
—
7
70
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
44
573
0.77
0.98
1.3
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
195
1721
1.14
0.98
1.1
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
139
1198
1.16
0.98
1.0
1.1
—
15.9
—
0
12
(40762887) Creatinine [Moles/volume] in Blood
5
23
2.17
0.98
1.0
1.1
—
—
—
0
0
(3017950) Salicylates [Moles/volume] in Serum or Plasma
5
23
2.17
0.98
1.2
1.7
umol/l
—
2258.4
—
0
5
(3016244) Insulin [Units/volume] in Serum or Plasma
79
647
1.22
0.98
2.8
3.5
mu/l
38.6
28.3
1.00
74
612
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
36
1.94
0.97
1.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
54
683
0.79
0.97
7.3
6.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
15
92
1.63
0.97
1.3
1.7
umol/l
55.4
42.0
0.52
15
92
(3023323) Follitropin [Units/volume] in Serum or Plasma
530
4927
1.08
0.96
1.4
1.3
iu/l
27.8
30.2
0.98
448
4225
(3009214) Lutropin [Units/volume] in Serum or Plasma
343
3132
1.10
0.95
1.4
1.4
u/l
9.8
9.9
0.09
277
2541
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
245
2199
1.12
0.95
2.9
3.5
u/ml
209.5
893.2
1.48
224
2008
(3040893) Potassium [Moles/volume] in Capillary blood
6
27
2.22
0.93
5.3
1.9
mmol/l
4.1
4.4
—
6
27
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
30
217
1.38
0.93
1.7
1.2
%
115.9
105.1
1.24
30
204
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
105
1230
0.85
0.89
1.1
1.0
u/ml
0.2
0.6
0.90
34
258
(3034426) Prothrombin time (PT)
51
403
1.27
0.88
1.3
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
157
1784
0.88
0.88
1.5
1.6
—
—
—
0
0
(4027681)
81
674
1.20
0.88
1.3
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
362
3932
0.92
0.88
2.0
1.8
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
15
95
1.58
0.87
1.0
1.1
g/l
18.5
17.9
0.12
15
80
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
388
3584
1.09
0.86
1.7
1.8
nmol/l
42.9
40.5
0.74
374
3479
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
504
5394
0.93
0.84
2.7
3.5
u/ml
32.8
56.5
2.61
484
5201
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
21
145
1.45
0.84
2.3
1.5
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
6
31
1.94
0.84
1.0
1.2
mmol/l
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
29
213
1.36
0.84
1.6
2.0
umol/l
16.8
16.8
0.00
29
213
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
11
65
1.69
0.82
1.1
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
291
2661
1.10
0.82
1.3
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
37
284
1.30
0.81
2.0
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
67
553
1.21
0.81
1.2
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
38
293
1.30
0.81
1.2
1.1
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
6.3
—
0.2
—
0
24
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
14
90
1.56
0.78
1.1
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
3746
36709
1.03
0.78
4.4
4.7
ug/l
2.1
3.0
4.36
3339
33144
(3025130) Human papilloma virus identified in Specimen
150
1329
1.13
0.77
1.7
1.7
—
—
—
0
0
(3039000) Anion gap in Blood
266
2432
1.10
0.77
7.3
7.4
mmol/l
11.4
11.2
0.33
241
2177
(40758292) HTLV I+II Ab panel - Serum
26
191
1.36
0.76
1.4
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
266
2433
1.10
0.76
7.3
7.4
mmol/l
104.2
105.2
3.13
241
2178
(3016330) Potassium [Moles/time] in 24 hour Urine
22
157
1.40
0.76
1.5
1.3
—
90.3
—
0
7
(4198724)
61
503
1.21
0.76
1.8
2.6
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
212
2339
0.90
0.75
1.4
1.4
pmol/l
117.7
151.9
0.65
206
2273
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
15
99
1.52
0.75
1.1
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
15
99
1.52
0.75
2.1
2.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
9
53
1.70
0.75
6.9
8.7
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
70
586
1.20
0.75
8.1
5.8
u/ml
37.4
6339.5
0.57
21
111
(40768795) Lymph node Pathology biopsy report
125
1097
1.14
0.74
1.3
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
13
83
1.57
0.74
1.2
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
55
450
1.22
0.74
1.2
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
160
0.62
0.73
1.2
3.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
136
0.59
0.72
1.3
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
139
1232
1.13
0.72
2.4
2.4
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
10
60
1.67
0.72
3.0
2.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
114
999
1.14
0.70
3.0
3.0
—
—
—
0
0
(3025315) Body weight
15
101
1.49
0.70
6.9
4.1
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
28
212
1.32
0.70
1.0
1.3
mg/l
196.1
62.2
0.30
20
156
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
54
445
1.21
0.69
1.0
1.1
ng/l
690.9
553.4
0.07
12
100
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
40
319
1.25
0.68
4.6
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
40
319
1.25
0.68
4.5
2.8
—
—
—
0
0
(3013762) Body weight Measured
7
42
1.67
0.68
1.3
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
16
110
1.46
0.68
2.1
2.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
34
266
1.28
0.68
1.1
1.2
pmol/l
447.2
311.1
0.24
21
198
(3035880) pH of Pleural fluid
65
547
1.19
0.67
1.4
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
155
1725
0.90
0.67
1.1
1.1
u/ml
0.6
1.9
3.74
44
406
(40757373) Influenza virus identified in Isolate
28
214
1.31
0.66
1.4
1.7
—
—
—
0
0
(3024471) HLA-A [Type]
49
402
1.22
0.66
1.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
25
188
1.33
0.66
2.0
1.5
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
23
171
1.35
0.65
1.3
1.1
—
—
—
0
0
(4268621)
131
1167
1.12
0.65
2.4
2.3
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
28
215
1.30
0.64
1.0
1.2
%
83.6
71.0
—
7
71
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
5
29
1.72
0.64
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
131
1170
1.12
0.63
1.2
1.2
—
—
—
0
0
(4281824)
104
1179
0.88
0.63
1.2
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
123
1379
0.89
0.62
1.1
1.1
u/ml
3.7
4.0
0.06
51
530
(3010375) cycloSPORINE [Mass/volume] in Blood
63
534
1.18
0.62
23.9
26.6
ug/l
123.1
116.4
0.24
53
434
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
11
71
1.55
0.62
1.1
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
18
130
1.39
0.61
1.1
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
21
156
1.35
0.60
1.9
2.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
17
122
1.39
0.60
1.7
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1586
16317
0.97
0.59
1.5
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
24
183
1.31
0.59
1.3
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
32
254
1.26
0.59
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
119
1062
1.12
0.59
1.6
1.6
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
72
621
1.16
0.58
2.1
2.1
ug/l
1.9
2.4
1.12
56
522
(3026470) Cobalt [Mass/volume] in Blood
74
640
1.16
0.58
2.0
2.0
ug/l
2.7
3.7
0.92
66
562
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
11.5
—
0
15
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
78
678
1.15
0.58
1.2
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
45
373
1.21
0.57
1.1
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
15
106
1.42
0.57
1.2
1.0
—
—
—
0
0
(4035726)
997
9621
1.04
0.56
1.4
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
59
503
1.17
0.56
1.7
1.8
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
11
73
1.51
0.56
1.2
1.2
—
2.2
—
0
9
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
24
185
1.30
0.56
2.0
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
118
1060
1.11
0.54
1.0
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
14
99
1.41
0.54
1.4
1.1
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
20
151
1.32
0.53
1.3
1.3
%
37.1
58.9
—
8
69
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
90
797
1.13
0.52
1.3
1.2
—
—
—
0
0
(4094501)
293
3120
0.94
0.51
1.1
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
31
380
0.82
0.50
1.9
1.8
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
27
215
1.26
0.50
1.0
1.2
%
91.5
77.3
—
6
74
(3014133) Dog dander IgE Ab [Units/volume] in Serum
134
1472
0.91
0.50
1.1
1.1
u/ml
4.7
3.8
0.25
50
552
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
38
315
1.21
0.50
1.4
1.4
%
73.4
72.2
0.24
38
301
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
77
678
1.14
0.50
1.1
1.1
ratio
1.0
1.1
0.36
29
235
(3032868) Hemoglobin electrophoresis panel in Blood
14
101
1.39
0.49
1.4
1.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
97
868
1.12
0.49
1.0
1.1
mg/l
256.2
261.3
0.08
81
761
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
99
888
1.12
0.48
1.1
1.2
mg/l
41.0
40.2
0.06
77
741
(4024509)
86
965
0.89
0.48
1.8
1.5
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
11
155
0.71
0.48
1.1
1.4
nmol/l
0.2
0.3
—
6
105
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
51
437
1.17
0.48
2.6
2.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
27
217
1.24
0.47
2.9
2.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
25
311
0.80
0.47
1.8
1.6
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
16
211
0.76
0.47
8.5
7.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
14
103
1.36
0.45
1.0
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
28
228
1.23
0.45
1.5
1.6
ug/l
0.4
0.4
0.13
19
150
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
112
1.34
0.44
1.0
1.1
—
—
—
0
0
(4038314)
10
69
1.45
0.44
1.2
1.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
10
69
1.45
0.44
1.0
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
7
51
1.37
0.44
2.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
1026
10560
0.97
0.44
1.4
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
25
307
0.81
0.43
1.3
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
22
175
1.26
0.43
1.7
1.8
pmol/l
58.6
51.4
0.12
16
146
(3024932) HLA-DR beta [Type]
46
397
1.16
0.41
1.1
1.1
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
17
217
0.78
0.41
2.7
2.9
—
—
—
0
0
(3035060) Mercury [Moles/volume] in Blood
0
16
0.00
0.41
0.0
2.1
—
11.8
—
0
9
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
27
326
0.83
0.40
1.3
1.2
—
—
—
0
0
(3020618) Glucose [Moles/volume] in Synovial fluid
5
34
1.47
0.40
1.0
1.0
mmol/l
5.4
6.0
—
5
21
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
72
645
1.12
0.39
1.1
1.1
nmol/l
13.8
8.3
0.33
12
132
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
28
233
1.20
0.38
1.2
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
18
142
1.27
0.38
1.2
1.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
203
0.79
0.37
6.8
5.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
35
299
1.17
0.37
1.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
15
116
1.29
0.37
1.1
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
19
235
0.81
0.36
1.0
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
34
290
1.17
0.36
1.1
1.3
nmol/l
131.5
125.2
0.10
26
217
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
88
801
1.10
0.36
1.3
1.4
umol/l
12.2
12.5
0.13
83
761
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
12
90
1.33
0.35
1.3
1.3
ml/s/173m2
2.5
1.1
—
7
65
(40758358) Immune stain study
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(4015189)
34
291
1.17
0.35
2.3
2.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
9
122
0.74
0.35
1.4
1.2
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
36
310
1.16
0.35
1.4
1.4
mu/l
372.8
413.5
0.28
36
296
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
63
565
1.12
0.35
38.0
34.6
ug/l
7.6
7.4
0.18
58
515
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
176
1654
1.06
0.34
1.1
1.1
%
122.4
117.6
1.15
164
1491
(3038071) Oxygen [Partial pressure] in Mixed venous blood
22
265
0.83
0.34
8.0
7.3
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
11
82
1.34
0.34
1.3
2.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
6
45
1.33
0.33
1.2
1.1
nmol/l
183.3
256.0
—
6
45
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
45
396
1.14
0.33
2.6
3.0
umol/l
27.9
28.0
0.02
27
299
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
94
1022
0.92
0.33
4.6
4.8
u/ml
34.0
85.7
2.53
34
300
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1124
10997
1.02
0.32
3.5
4.1
ug/l
28.9
24.7
0.17
921
8900
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
12
153
0.78
0.30
3.8
2.4
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
164
1547
1.06
0.30
5.4
2.5
%
13.3
13.2
1.03
164
1522
(4306422)
181
1714
1.06
0.29
1.2
1.2
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
19
157
1.21
0.29
1.1
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
67
612
1.10
0.28
1.0
1.1
u/l
0.9
1.1
3.85
26
283
(3002523) Influenza virus A Ag [Presence] in Specimen
173
1825
0.95
0.28
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
113
1056
1.07
0.28
1.3
1.4
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
40
355
1.13
0.28
1.3
1.2
%
31.0
21.7
—
6
53
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
9
117
0.77
0.27
1.1
1.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
9
117
0.77
0.27
1.2
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
9
120
0.75
0.27
1.1
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
37
328
1.13
0.26
1.3
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
80
740
1.08
0.26
1.9
1.7
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
18
150
1.20
0.26
1.1
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
12
95
1.26
0.26
1.1
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
72
0.69
0.26
4.4
5.3
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
73
0.68
0.26
1.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
23
267
0.86
0.25
1.2
1.1
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
9
73
1.23
0.25
4.2
2.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
9
73
1.23
0.25
1.1
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
19
160
1.19
0.25
1.3
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
349
3377
1.03
0.24
1.5
1.5
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
10
78
1.28
0.24
1.1
1.1
u/l
8.5
12.3
—
10
78
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
47
517
0.91
0.24
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
152
1598
0.95
0.24
1.9
1.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
25
286
0.87
0.23
1.0
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
26
227
1.15
0.23
1.2
1.1
umol/24h
0.6
1.0
0.82
14
112
(3007463) Buprenorphine [Presence] in Urine
5
39
1.28
0.23
13.8
6.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
44
484
0.91
0.23
1.3
1.7
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
16
134
1.19
0.22
1.0
1.3
u/l
104.7
322.8
—
10
101
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
30
266
1.13
0.22
1.4
1.3
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
22
191
1.15
0.21
1.1
1.2
mmol/l
1.4
1.7
0.23
11
116
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
19
163
1.17
0.21
1.0
1.1
ug/l
77.9
80.6
0.11
14
135
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
11
0.00
0.21
0.0
1.2
—
36.7
—
0
11
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036005) Urine sediment comments by Light microscopy Narrative
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
47
513
0.92
0.21
1.1
1.1
%
102.4
95.9
1.15
36
409
(3020934) Sesame Seed IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.7
—
0
6
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
12
0.00
0.21
0.0
1.2
—
71.8
—
0
12
(3004446) Plasmodium sp identified in Blood by Light microscopy
12
98
1.22
0.21
2.4
2.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
45
411
1.10
0.21
5.2
5.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
25
220
1.14
0.21
1.4
1.9
ug/l
1.9
2.2
0.25
17
119
(40758047) Lysozyme [Mass/volume] in Pleural fluid
8
104
0.77
0.21
1.4
1.2
mg/l
10.3
8.9
—
8
93
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
48
440
1.09
0.21
1.1
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
43
1.16
0.21
5.2
9.4
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
(3022670) pH of Venous cord blood
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
175
1824
0.96
0.20
1.1
1.1
—
—
—
0
0
(44806071)
19
164
1.16
0.20
1.1
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
31
278
1.12
0.20
1.8
1.5
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
55
509
1.08
0.20
1.1
1.1
u/ml
5.9
7.5
—
9
92
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
6
50
1.20
0.19
1.0
1.0
u/ml
62.7
15.4
—
6
41
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
124
1301
0.95
0.19
3.3
3.3
nmol/l
51.4
6.3
0.48
116
1268
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
126
1201
1.05
0.19
1.5
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
3059
30349
1.01
0.19
1.4
1.4
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
6
51
1.18
0.19
1.2
1.6
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
6
51
1.18
0.19
1.2
1.6
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
23
203
1.13
0.19
2.3
1.9
mmol/l
1.2
1.2
0.01
23
198
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
45
488
0.92
0.18
1.4
1.5
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
25
280
0.89
0.18
1.1
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
13
109
1.19
0.18
1.2
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
50
463
1.08
0.18
12.8
9.9
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
46
425
1.08
0.18
1.1
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
10
121
0.83
0.18
1.1
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
13
110
1.18
0.17
2.8
10.6
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
66
0.76
0.17
1.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
17
194
0.88
0.16
3.4
3.0
u/l
8663.2
1776.0
0.48
17
177
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
64
604
1.06
0.15
1.5
1.6
mmol/l
8.4
7.7
0.89
39
362
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
9
81
1.11
0.15
1.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
25
275
0.91
0.14
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
340
3474
0.98
0.14
1.4
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
102
1063
0.96
0.14
1.3
1.4
ug/l
3.0
3.6
0.66
84
916
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
16
141
1.13
0.13
1.1
1.2
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
24
218
1.10
0.13
3.0
4.8
u/l
41.6
71.6
—
5
77
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
22
199
1.11
0.13
1.3
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
22
199
1.11
0.13
1.3
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
22
199
1.11
0.13
1.3
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
13
113
1.15
0.13
1.2
1.1
umol/24h
1.8
1.9
0.11
13
113
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
60
569
1.05
0.13
1.4
1.3
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
66
628
1.05
0.13
1.0
1.0
u/ml
4.7
1.0
0.41
14
145
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
20
220
0.91
0.12
2.3
3.0
ng/l
99.7
132.6
—
10
97
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
74
709
1.04
0.11
1.1
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
28
301
0.93
0.10
7.5
7.4
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
21
229
0.92
0.10
1.1
1.3
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
32
299
1.07
0.10
1.1
1.4
mmol/l
2.8
3.3
0.39
27
275
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
63
603
1.04
0.10
1.4
1.3
mmol/l
5.8
5.8
0.28
58
574
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
19
173
1.10
0.10
1.0
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
130
1337
0.97
0.10
1.7
2.0
ug/l
25.2
23.6
0.13
124
1314
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
17
154
1.10
0.10
1.1
1.2
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
5
45
1.11
0.09
2.0
1.4
—
—
—
0
0
(4212803)
12
106
1.13
0.09
1.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
124
0.89
0.09
1.0
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
52
498
1.04
0.08
2.3
2.3
umol/l
60.5
53.2
0.76
45
414
(1761868) Lipid panel - Serum or Plasma
4081
40938
1.00
0.08
3.2
2.8
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
6
58
1.03
0.08
1.2
1.1
mmol/l
7.5
8.3
—
6
58
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
150
1533
0.98
0.08
1.4
1.4
nmol/l
0.3
0.4
2.03
106
1161
(37021550) Renin [Units/volume] in Plasma --upright
26
244
1.07
0.08
1.4
1.3
mu/l
118.9
67.8
0.70
18
185
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
7
67
1.04
0.08
3.1
3.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
8
74
1.08
0.07
3.4
5.4
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
15
138
1.09
0.06
1.3
1.5
mmol/l
7.0
7.0
—
6
46
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1322
13159
1.01
0.06
4.6
4.4
%
30.8
32.0
3.57
969
9135
(3015076) Soybean IgE Ab [Units/volume] in Serum
55
567
0.97
0.05
1.0
1.0
u/ml
0.2
1.8
—
8
75
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
211
2083
1.01
0.05
1.1
1.1
u/ml
1.3
1.4
0.04
84
818
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
62
636
0.97
0.05
1.3
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
27
282
0.96
0.04
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
77
754
1.02
0.04
2.2
1.7
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
22
231
0.95
0.04
2.6
2.4
mmol/l
11.0
7.4
0.64
14
135
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
46
473
0.97
0.04
1.6
1.7
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
15
141
1.06
0.03
1.1
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
25
260
0.96
0.03
1.1
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
13
122
1.07
0.02
1.2
1.1
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
12
128
0.94
0.02
1.2
1.3
%
35.7
25.0
0.53
12
97
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
27
278
0.97
0.02
1.1
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
17
177
0.96
0.01
1.2
1.2
ng/l
145.5
129.8
—
10
121
(3008401) Mugwort IgE Ab [Units/volume] in Serum
180
1809
0.99
0.01
1.1
1.1
u/ml
0.6
1.1
0.75
80
742
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
49
484
1.01
0.00
1.4
1.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
188
1884
1.00
0.00
1.1
1.1
u/ml
3.8
5.4
0.80
89
950
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
11
114
0.96
0.00
1.0
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
20
196
1.02
0.00
1.0
1.5
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
13
132
0.98
0.00
1.2
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
15
148
1.01
0.00
1.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
24
245
0.98
0.00
1.4
1.4
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
18
175
1.03
0.00
2.3
2.4
ug/l
4.0
3.9
—
7
61
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
22
225
0.98
0.00
3.0
6.5
%
72.4
69.3
0.24
16
181
(3006576) Bicarbonate [Moles/volume] in Blood
40
402
1.00
0.00
5.3
6.5
mmol/l
25.2
25.0
0.11
33
367
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
46
463
0.99
0.00
2.5
1.7
umol/l
27.7
28.8
0.36
46
447
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
156
1558
1.00
0.00
1.3
1.3
mmol/l
8.1
7.3
1.81
116
1140
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
12
119
1.01
0.00
1.3
3.4
mg/l
1.2
1.1
—
7
79
(3042010) Triglyceride [Moles/volume] in Pleural fluid
15
149
1.01
0.00
1.0
1.3
mmol/l
3.5
1.3
—
9
100
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
9
96
0.94
0.00
1.2
2.0
umol/l
1.6
1.3
—
9
86
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
8
84
0.95
0.00
5.3
4.9
—
—
—
0
0
(36304079) Mucus [Presence] in Urine sediment
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009179) Lactate [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
1.8
—
0
5
(3000219) Insulin receptor Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
9
98
0.92
0.00
1.9
2.6
umol/l
189.9
414.3
—
9
92
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
5
51
0.98
0.00
1.0
1.0
—
—
—
0
0
(3044590) Delta aminolevulinate [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
15.6
—
0
5
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
7
69
1.01
0.00
1.0
1.0
—
—
—
0
0
(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
9
98
0.92
0.00
1.4
1.2
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
52
0.96
0.00
2.0
1.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
6
67
0.90
0.00
1.0
1.2
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
81
0.99
0.00
1.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
7
73
0.96
0.00
1.4
1.4
umol/24h
231.0
328.8
—
7
73
(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
8
79
1.01
0.00
4.9
2.6
mg/l
2.0
2.4
—
8
65
(3014178) Parietal cell Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002853) Influenza virus B Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
79
1.01
0.00
1.0
1.1
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
15
150
1.00
0.00
1.7
1.4
%
16.3
10.1
—
8
78
Mortality – FinRegistry
↥Association
Association between endpoint L12_PSORIASIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_PSORIASIS | 1.355 [1.24, 1.48] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.073 |
During the follow-up period (1.1.1998 — 31.12.2019), 3798 out of 32117 females with L12_PSORIASIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_PSORIASIS | 1.643 [1.51, 1.79] | < 0.001 |
| Birth year | 0.981 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 5782 out of 32694 males with L12_PSORIASIS died.
Mortality risk
Mortality risk for people of age
years, who have L12_PSORIASIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.123% | 0.224% |
| 5 | 0.726% | 1.604% |
| 10 | 1.999% | 3.926% |
| 15 | 3.677% | 7.445% |
| 20 | 6.21% | 12.45% |
Relationships between endpoints
↥Index endpoint: L12_PSORIASIS – Psoriasis
GWS hits: 58
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data